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1. Introduction 
The introduction highlights molecular mechanisms of the migration of eukaryotic cell and 
its importance for an effective immune response on the example of dendritic cells; 
includes a brief description of biology of dendritic cells and their migratory property. 
Followed with discussion how some pathogens (bacteria, viruses and parasites) favor by 
modulating the host cell migration properties. All in all, the introduction provides the 
reader of this thesis a sound basis for understanding the subsequent aspects of the 
results and discussion parts of the thesis. 
 
 
1.1. Cell migration 
 
1.1.1. The definition and discovery 
Cell migration is an essential feature of eukaryotic life, a central process in the 
development and maintenance of multicellular organism. Tissue formation 
during embryonic development, wound healing, angiogenesis, nerve growth and immune 
responses - all require the orchestrated movement of cells in particular directions to 
specific locations. Errors during this process have serious consequences, including mental 
retardation, vascular disease, tumor formation and metastasis [1,2]. 
Cell movement was observed as early as 1675 when Anton van Leeuwenhoek discovered 
the tiny creatures crawling in rainwater across his microscope slide. In a letter published 
by the Philosophical Transactions of the Royal Society of London, he described living 
atoms that put forth little horns, extended and contracted, and had pleasing and nimble 
motions [3]. Despite the early discovery, the molecular mechanisms behind cell 
movement have become a scientific focus only in the past few decades. Advances in 
fluorescence microscopy, molecular biology and biochemistry have enabled the 
understanding of the processes underlying motility and the identification of the major 
proteins behind these processes [4].  
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1.1.2. Main steps in cell migration 
Cell migration requires series of repetitive, integrated processes to produce coordinated 
cellular movements [2]. The migration process of cultured cells is described as a four step 
cycle consisting of: (i) the protrusion of a lamellipodia and filopodia, the actin rich filaments, 
at the leading edge. (ii) Following the protrusions, new, small, punctate sites of cell 
attachment to the extracellular matrix (ECM), focal complexes are formed close to the 
leading edge, the precursors of larger, more elongated contacts known as focal adhesion. 
(iii) The next event in the migratory process is acto-myosin based cell-body translocation 
(iv) and the final phase is the release of cell contacts at the rear of the cell (Figure 1) 
[5,6,7].  
 
Figure 1: Major steps of endothelial cell migration. 
Endothelial cell migration can be divided in 4 sequential events: A. Cdc42 dependent 
sensing of the motile stimuli by filopodia; cellular extension involving the Rac1-dependent 
formation of protruding lamellipodia; B. Attachment of the protrusions to the 
extracellular matrix at focal adhesions; C. Stress fiber–mediated contraction of the cell-
body allowing forward progression; D. Rear release by stress fiber–mediated traction 
forces. 
 
 
Optimal cell migration requires a quick and precise regulation by spatio-temporally 
integrated components in each of these 4 steps that will be discussed in followed manner. 
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1.1.2.1. Protrusion of lamellipodia and filopodia 
Migration is initiated by protrusion of the leading edge and formation of new actin 
filaments. The process is dependent on an extensive remodeling of the actin cytoskeleton 
[2]. For protrusion, mainly two types of organelles are described, branched filaments 
leading to the sheet like lamellipodium and the spike like filopodium [7]. Lamellipodia as 
characteristic feature at the leading edge of motile cells are believed to have two major 
functions for cell migration. Firstly, actin polymerization closely behind the lamellipodial 
leading edge creates the necessary forces to pull the front of the cell in the direction of 
movement [8,9]. Furthermore, the formation of new adhesion structures to the substrate 
is described to occur closely behind the leading edge by forming focal complexes that can 
develop to mature focal adhesions within the lamellipodium [10]. In contrast, filopodia 
are thin, dynamic membrane extensions comprising tight bundles of parallel oriented, 
cross-linked actin filaments [11]. Their proximal parts are usually embedded in the 
lamellipodial actin network whereas their distal ends can either protrude beyond the 
leading edge or remain as microspikes within the lamellipodium [12]. 
Functionally, filopodia are described as structures mainly probing the substrate for proper 
matrix composition and therefore adhesion properties [7]. The generation of either 
branched or linear filament arrays is triggered by the receptors in the plasma membrane 
and signalling through the small GTPases such as Rho, Rac, and Cdc42. They can trigger 
nucleation of new actin filaments via specific downstream pathways. Rac induces 
lamellipodia and Cdc42 stimulates filopdia (Figire 1)[13].  
The primary complex involved in branching of actin filaments is the actin-nucleating Arp 
(actin-related protein) 2/3 complex, which is composed of multiple F-actin-binding 
proteins [2]. The main activators of Arp2/3 complex are the WASP family proteins, of 
which the best known are Wiskott-Aldrich Syndrome Protein (WASP) and Suppressor of 
cyclic AMP receptor mutation/WASP and Verprolin homologous protein (SCAR/WAVE), 
which have multiple isoforms in mammals. WASP family proteins act as scaffolds that 
couple signal intermediates to the initiation of actin branches by the Arp2/3 complex, and 
thus allow signalling to catalyze rapid filament growth [1]. Arp2/3 complex nucleates new 
actin filaments in the form of branches on the sides of preexisting filaments leading to 
lamellipodia. Spiky filopodia can be formed in two ways: from branched networks by the 
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actions of actin bundling proteins such as fascin, or directly nucleated as unbranched 
actin filaments by the formin family of proteins [1].  
Another important regulator in formation of actin containing structures is the actin 
depolymerizing factor (ADF)/cofilin family of proteins. ADF and cofilin are actin-binding 
proteins that have filament disassembly/severing activity and are required for breaking 
down older parts of the actin network so that the resulting globular G-actin subunits can 
be recycled and re-used. Furthermore, cofilin is required at the initiation of protrusion for 
barbed-end-mediated actin assembly at the leading edge and thereby increases levels of 
Arp2/3-mediated polymerization [1,14].  
Various guanine nucleotide exchange factors (GEFs, which activate GTPases) and GTPase 
activating proteins (GAPs, which cause inactivation) provide specificity and thus allow 
signalling networks to drive multiple cell processes via a relatively small (around 25 in 
humans) set of Rho family members. Additionally, lipids and proteins in the plasma 
membrane provide spatial information and an additional level of control for actin-based 
protrusions [1].  
Lamellipodia/filopodia formation is dynamically regulated by phosphatases. Rac and 
Cdc42 are opposed by phosphatase and tensin homologue (PTEN). Rac activation is also 
opposed indirectly by protein tyrosine phosphatase (PTP)-PEST [2,14,15]. The ADF/cofilin 
can be dephosphorylated by protein phosphatases (PP) 1A and PP2A to stimulate 
migration (Figure 1.A) [2]. 
Lamellipodia and filopodia are seen as the main types of protrusions that cells produce 
when moving on 2D surfaces. When cells are moving in 3D matrices, they need to 
squeeze through the matrix, rather than just walk across it. They frequently appear to use 
fat, bubble-like protrusions called blebs, which are initially driven by hydrostatic pressure 
rather than by actin polymerization. Cells in 3D matrices also move using pseudopods that 
are bulkier and rounder than the sheet-like lamellipodia seen in cells moving on flat 
surfaces [16-19]. 
 
1.1.2.2. Formation of focal adhesions 
Adhesion site formation starts with integrin molecules binding to the extracellular matrix 
(ECM). These dot-like so called focal complexes (FCs) can mature and grow in size to form 
focal adhesions (FAs) that built up more than 100 proteins [20,21]. FA are highly dynamic 
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structures and are the master control machinery of cell migration [22]. They link the ECM 
with the actin cytoskeleton and serve as bidirectional mechanical biosensors that allow 
cells to integrate intracellular and extracellular cues. Additionally, closely regulated 
turnover of FA proteins within FA sites allows cells to respond appropriately to their 
environment, thereby impacting on cell shape and function [22].  
Three basic categories of proteins are recruited to FAs: (i) integrin-binding proteins, (ii) 
adaptors and/or scaffolding proteins that lack intrinsic enzymatic activity, and (iii) 
enzymes. Talin is an example of a protein that directly binds to integrin cytoplasmic 
domains and is important for regulating integrin activation and signalling [23]. Adaptors 
and/or scaffolding factors, such as vinculin, paxillin, and α-actinin, link integrin-associated 
proteins with actin or other proteins. The enzymes that modify integrin downstream 
effectors include the non-receptor tyrosine kinases FAK and Src [20-24]. 
The transformation from FCs to FAs highly depends on regulatory tyrosine 
phosphorylation and dephosphorylation events (Figure 1.B) as well as on forces applied to 
adhesion sites by the acto-myosin contractile apparatus. Myosin inhibitors diminish 
adhesion formation and induce accumulation of FCs [7]. 
 
1.1.2.3. Cell-body contraction  
The cell is pulled forward, mainly by contractile forces that are produced by myosin 
motors sliding on actin filaments, presented in the cell body and at the rear [4,25]. The 
contractile F-actin module extends from nascent FAs at the lamellipodium base to near 
the nucleus and is comprised of F-actin-myosin II networks and bundles in the lamella, 
convergence zone, and central cell area [26]. The slow myosin II-powered F-actin 
retrograde flow from the lamella and anterograde flow from the central cell region merge 
in the convergence zone, where F-actin remains stationary and depolymerizes [27]. This 
myosin II-driven actin convergence is thought to pull on strong FAs at the front to 
generate traction in the third step of cell migration [4,28]. 
 
1.1.2.4. Tail retraction 
Trailing adhesions restrain the cell body and maintain cell spreading but they need to be 
released for successful cell body relocation. The regulation of adhesion turnover 
modulates the relative rates of association versus dissociation of molecules at adhesion 
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sites. Src and/or FAK kinase activity regulate the recruitment of protein complexes to 
adhesions. The phosphorylation of paxillin kinase linker (PKL) promotes the binding of PKL 
to the adaptor protein, paxillin. Paxillin likely induces adhesion turnover depending on 
its phosphorylation state [29]. 
Besides phosphorylation-associated regulation, it is likely that proteolysis of adhesion 
components can also contribute to the turnover process. Talin proteolysis by calpain has 
been shown to stimulate the dissociation of several major adhesion components, 
including paxillin, vinculin, and zyxin [30,31]. 
Coordinated asymmetry of adhesion disassembly as well as the assembly in the leading 
edge of the migrating cell is regulated by microtubuls, which in general play a key role in 
the polarized distribution of signals within a cell. There are several ideas how the 
regulation may work. First, microtubules could facilitate adhesion disassembly by local 
release of tension. Indeed, the tyrosine kinase Arg, which requires microtubules for 
proper localization and activity, can inhibit Rho and p190RhoGAP [32], RhoA 
activates p160ROCK (ROCK1) that is known to be required for tail retraction [33]. 
Additionally, microtubules could release tensile forces by the uncoupling of adhesion 
proteins through calpain-driven proteolysis. Finally, the ripping off of adhesions by cell 
edge retraction at the rear may also be microtubule dependent since it requires myosin 
contractility. Contractility is strongly regulated by the microtubule-associated Rho GEFs, 
H1 and Lfc [34]. These GEFs reside on the microtubule lattice in an inactive form where 
they can be released and cause local Rho activity upon microtubule depolymerization [35]. 
 
Cell migration and the tight regulation of it have a great importance for a proper function 
of immune system, discussed on the example of dendritic cell migration in the following 
chapter. 
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1.2. The effective clearance of pathogen by immune system  
The immune system can be broadly divided into innate and adaptive components, with 
extensive crosstalk between the two [36]. The innate immune response functions as the 
first line of defense against infections. It consists of soluble factors, such as complement 
proteins, and diverse cellular components including granulocytes (basophils, eosinophils 
and neutrophils), mast cells, macrophages (MΦs), dendritic cells (DCs) and natural killer 
(NK) cells. The adaptive immune response is slower to develop, but manifests as 
increased antigenic specificity and memory. It is mediated by CD4+ and CD8+ T 
lymphocytes, B cells, and antibodies [37]. 
The cross talk between innate and adaptive systems is made by antigen presenting cells 
(APC) and the cytokines secreted from different cell types of the immune system.  
 
1.2.1.  Dendritic cell – a linker between adaptive and innate immune 
systems  
DCs are the most powerful and versatile APCs in the immune system. They acquire and 
process antigens (Ags). At the same time, DCs express high levels of co-stimulatory 
molecules in order to present Ags and drive T-cell activation effectively. In addition to 
initiation of the adaptive immunity, DCs fine-tune immune responses by instructing T-cell 
differentiation and polarization. DCs transmit a distinct set of commands to T cells that is 
based on their state of differentiation or maturation. The outcome of these instructions 
ranges from humoral to cytolytic to regulatory T-cell responses [38]. Thus, DCs are 
specialized in linking innate and adaptive immune systems. These unique functions of DCs 
are mediated by combination of different properties: localization, high phagocytic activity 
and mobility.  
 
1.2.2. DC types and subsets 
DCs represent a heterogenous cell population. They reside in most peripheral tissues, 
particularly at the sites of interface with environment (skin and mucosa), where they 
represent 1–2% of the total cell numbers. Additionally, in the absence of ongoing 
inflammatory and immune responses, DCs (migratory DCs) constitutively patrol through 
the blood, peripheral tissues, lymph and secondary lymphoid organs [38].  
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The DC system contains conventional dendritic cells (cDCs), which already have dendritic 
form and exhibit DC functions in steady state, and pre-DCs, that require microbial or 
inflammatory stimulus to further develop to DCs. Examples of pre-DCs are plasmacytoid 
dendritic cells (type I interferon producers DCs) (pDCs) and monocytes, (precursors of 
macrophages that can also serve as pre-DCs) [39]. 
DCs in the skin are diverse: some are resident in the dermis, named dermal DCs; some are 
resident in the epidermis, Langerhans cells (LCs); and others are recruited from the blood 
and remain only transiently in the skin before entering lymphatic vessels. LCs have been 
investigated in the most detail with regard to migration to lymph nodes (discussed briefly 
in next sub chapter 2.4.)[40]. 
Although the common functions of DCs are antigen-processing and T-lymphocyte 
activation, they differ in surface markers, migratory patterns, and cytokine output. These 
differences make heterogeneity of DCs, which in turn can determine the fate of the T cells 
they activate. The recent studies demonstrated that DCs can be derived from both 
myeloid and lymphoid-restricted precursors. Moreover, it has been shown recently that 
both cDCs and pDCs can be generated by the Flt3 expressing hemopoietic progenitors 
regardless of their myeloid- or lymphoid-origin [39]. 
 
1.2.3.  DCs - professional Ag-presenting cells 
DCs are positioned as sentinels in all peripheral tissues and accumulate at the sites of 
pathogen entry, where they encounter foreign antigens [40]. DCs have high phagocytic 
activity, both in peripheral tissues and in secondary lymphoid organs. However, DCs 
joined the group of phagocytes more recently [38,39,41-46]. 
Phagocytes represent a heterogeneous family of cells that include neutrophils, MΦs and 
DCs. The first two cell types are critical effectors of innate immunity, as they both are 
involved in the immediate clearance of pathogens through local inflammatory responses. 
Unlikely, DCs are not directly involved in immediate pathogen clearance. In contrary to 
macrophages and neutrophils, the phagocytic–endocytic proteolysis in DCs is aimed at 
degrading proteins “partially” (processing) rather than “totally” [46]. To achieve partial or 
controlled proteolysis in their endocytic pathway, DCs have developed various 
specializations of their endosomal and phagosomal pathways, including a tight control of 
the pH. The pH in phagosomes is controlled by recruitment of two multisubunit 
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complexes, the NADPH oxidase (NOX2) and the V-ATPase. Neutrophils massively recruit 
NOX2 to early phagosomes during the oxidative burst, what leads to a transient 
alkalinization (up to pH 8) of the phagosomal lumen. The subsequent recruitment of the 
V-ATPase results in a rapid acidification and the pH drops to 5–4.5. In MΦs the respiratory 
burst is triggered during engulfment; the majority of ROS production takes place at the 
plasma membrane, thus the NOX2 activity is much less important than in neutrophils. A 
massive recruitment of the V-ATPase to phagosomes is observed very early during 
phagocytosis, resulting in a very strong acidification of the lumen. These processes are 
even different in DCs, a discrete but sustained recruitment of NOX2 to phagosomes 
together with low levels of V-ATPase activity provokes a stabilization of the phagosomal 
pH above neutrality for several hours [46]. As a result, DCs process and degrade the cargo 
relatively partially. 
Phagocytic DCs are referred to as immature. Immature DCs express a large array of 
phagocytic receptors, including lectins, scavenger receptors, Toll-like receptors (TLRs) and 
other pattern recognition receptors (PRRs). Selective expression of different phagocytic 
receptors on these DC subpopulations results in the selective uptake of different particles. 
A signal from pathogens, often referred to as a “danger signal”, induces DCs to enter a 
developmental program, maturation. The maturation transforms DCs into efficient APCs 
and T cell activators. During this process DCs process internalized antigens into proteolytic 
peptides. These peptides are loaded onto MHC class I and II molecules and subsequently 
exposed on the surface of DCs [38]. At the same time, DCs acquire a migratory phenotype 
associated with the up-regulation of CCR7 (a homing chemokine receptor) and express 
receptors linked with DC maturation, including co-stimulatory molecules: CD40, CD80, 
and CD86. On the way of maturation DCs lose the phagocytic capacity and acquire 
immunogenic phenotype [47]. 
One additional feature that make DCs professional APCs is formation of DALIS (Dendritic 
cell Aggresome-Like Induced Structures) [44,45], an accumulation of polyubiquitinated 
protein aggregates in the cytosol. DALIS formation is a transient event starting 6–8 h after 
activation of DCs with TLR-ligands or viruses and reaching a maximum at 15 hs. After 
around 20–24 hs no DALIS can be found anymore. At this time, DCs are thought to have 
reached the draining lymph nodes and have expressed co-stimulatory molecules. Thus, 
DALIS can function as antigen depots which delay the antigen presentation in DCs until a 
proper maturation status has been achieved [44,48-50]. 
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1.2.4.  Trafficking of DCs  
DCs are highly mobile cells. They are present in the right place at the right time for the 
regulation of immunity. Upon stimulation with foreign antigens, they readily relocate 
from peripheral tissues to secondary lymphoid organs to position themselves optimally 
with naive or central memory T cells. The trafficking of DCs to lymph nodes through 
afferent lymphatic vessels is crucial for the execution of their functions (Figure 2) [40,51]. 
Concomitant with the modifications of their antigen presentation abilities, DC maturation 
also induces massive migration of DCs out of peripheral tissues. The migratory phenotype 
of DCs includes modifications in the expression of chemokine receptors and adhesion 
molecules, as well as profound changes of the cytoskeleton organization. 
The chemokines that arise under inflammatory conditions act on CCR1, CCR2, CCR5 
and CCR6 to attract immature DCs to the affected sites. After antigen uptake, during 
maturation, chemokine receptor expression changes: CCR1, CCR2 and CCR5 are down-
regulated and replaced by CCR7 and CXCR4, thus enabling DCs to migrate in the 
draining lymph nodes in response to corresponding chemokines [51]. 
 
 
Figure 2: LC and dermal DC migration towards the lymph nodes (LNs) upon infection 
During inflammatory reactions caused by infection, pre-existing LCs and dermal DCs 
rapidly migrate to the peripheral LNs and are replaced by newly formed LCs and dermal 
mo-DCs derived from inflammatory Ly-6C+ monocytes recruited to the dermis. Dermal 
mo-DCs are phenotypically similar to dermal DCs and also migrate to the peripheral LNs 
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as mature DCs. Inflammatory monocytes are also recruited to the LNs and differentiate 
into mo-DCs. Finally, resident inflammatory CD8+ and CD8− DCs are also formed 
during infection, but their precursors have yet to be defined. 
 
 
DC migration to lymphatic vessels and positioning to lymph nodes is controlled 
prominently by CCR7, the “gate-keeper” chemokine receptor. Study of CCR7-deficient 
mice revealed a marked defect in DC migration to lymph nodes. However, the expression 
of CCR7 alone is not sufficient for DC migration, as it can be expressed in a biologically 
“insensitive” state. Signals that are expected to be found at sites of inflammation, 
including the lipid mediators cysteinyl leukotrienes and prostaglandin E2 and the ADP-
ribosyl cyclase CD38 [52,53] are required to sensitize CCR7 to its ligands CC-chemokine 
ligand 19 (CCL19) and CCL21. The mechanisms by which these mediators alter CCR7 
functionality is not known, but they probably trigger signalling events that, in turn, alter 
the signalling cascades that are engaged when CCR7 binds its ligands. The prevailing 
model to explain how CCR7+ DCs arrive at peripheral lymphatic vessels is that they 
respond to a chemotactic gradient of CCL19 and/or CCL21 that originates from the 
lymphatic vessel. But how the DCs enter the vessels, whether DC passage across the 
lymphatic endothelium is passive, or whether molecular interactions occur between the 
endothelium and the DCs, is not clear yet [51]. 
Some migratory DCs or their precursors from the blood can enter lymph nodes through 
the hematogenous route, the rout that naive lymphocytes use to access lymph nodes: 
passage across the specialized high endothelial venules (HEVs) within lymph nodes [52]. 
DCs derived from a peripheral organ or lymph node can generally mobilize back into 
blood and ultimately home to another organ. Mechanisms to reenter the bloodstream is 
hypothesited and could include either direct migration across vascular endothelium in the 
ablumenal-to-lumenal direction, or failure of DCs to be trapped in lymph nodes such that 
they emerge into efferent lymph that accesses the bloodstream [53]. 
These properties of DCs can be used by different pathogens as a strategy to spread the 
infection throughout the host - disseminate to blood steam or even to colonize certain 
organs.  
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1.3. Pathogens modulating host cell adhesion and migration 
Numbers of bacterial and parasite pathogens, various viruses are known to modulate host 
cell adhesion and migration properties. Some of them induce the arrest of the cell 
migration, such as inhibition of DC migration, thus delaying the Ag presentation 
properties to T cells and effective adaptive immune responses. Others induce the hyper 
activity of infected cell and by this promoting to the spread of the bacteria or viruses 
through the organism. 
  
 
1.3.1. Bacterial pathogens modulating host cell migration 
1.3.1.1. Helicobacter pylori 
Infection with Helicobacter pylori strains bearing cagA (cytotoxin-associated gene A)-
positive strains is the strongest risk factor for the development of gastric carcinoma, the 
second leading cause of cancer-related death worldwide [54]. CagA is a bacterial effector 
protein of H. pylori that is translocated via a type IV secretion system (T4SS) into gastric 
epithelial cells [58-60].  
CagA delivery results in a dramatic cellular elongation of epithelial cells referred to as 
"hummingbird" phenotype, which is characterized by the development of one or two long 
and thin protrusions resembling the beak of the hummingbird. It has been thought that 
the hummingbird phenotype is related to the oncogenic action of CagA [58-62]. 
Pathophysiological relevance for the hummingbird phenotype in gastric carcinogenesis is 
that infection with H. pylori carrying CagA with greater ability to induce the hummingbird 
phenotype is more closely associated with gastric carcinoma. Bacteria disrupt the 
organization and assembly of apical junctions in polarized epithelial cells [55]. Elevated 
motility of hummingbird cells may also contribute to invasion and metastasis of gastric 
carcinoma [55-57,63]. 
In host cells, CagA interacts with the SHP-2 phosphatase, C-terminal Src kinase, and Crk 
adaptor in a tyrosine phosphorylation-dependent manner and also associates with Grb2 
adaptor and c-Met in a phosphorylation-independent manner. Among these CagA targets, 
much attention has been focused on SHP-2 because the phosphatase has been 
recognized as a bona fide oncoprotein, gain-of-function mutations of which are found in 
various human malignancies. Stable interaction of CagA with SHP-2 requires CagA 
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dimerization, which is mediated by a 16-amino acid CagA-multimerization (CM)2 
sequence present in the C-terminal region of CagA. Upon complex formation, CagA 
aberrantly activates SHP-2 and thereby elicits sustained ERK/MAPkinase activation that 
promotes mitogenesis. Also, CagA-activated SHP-2 dephosphorylates and inhibits focal 
adhesion kinase (FAK), causing impaired focal adhesions. Both aberrant ERK activation 
and FAK inhibition by CagA-deregulated SHP-2 are involved in induction of the 
hummingbird phenotype [55-57]. 
Consistent with a model in which CagA causes cell elongation by inhibiting the 
disassembly of adhesive cell contacts at migrating cells lagging 
ends, immunohistochemical analysis revealed that focal adhesion complexes persist at the 
distal tips of elongated cell projections. The elongation phenomenon revealed that this 
phenotype is due to a cell retraction defect rather than from filopodial protrusions [63]. 
 
1.3.1.2. Listeria monocytogenes 
Listeria monocytogenes is a facultative intracellular, gram-positive bacterium that invades 
humans via the gastrointestinal tract and causes bacteremia as well as a variety of 
materno-fetal and CNS infections [64,65,66]. It invades and grows in most of the types of 
host cells, including macrophages and bone marrow myeloid precursors differentiated to 
monocytes in vitro [65,66]. Interactions between Listeria and mononuclear phagocytes 
are an interesting in vivo paradigm of the balance between inflammation and regulation 
because these cells can function as bactericidal effector cells but also can be permissive 
for intracellular bacterial growth. In particular, Ly-6Chigh monocytes serve as Trojan horses 
in the pathogenesis by transporting intracellular L. monocytogenes into the CNS [67]. 
L. monocytogenes infection increases the percentage of Ly-6Chigh monocytes in the blood. 
This is in accordance with their role as the main monocyte subset that exits the bone 
marrow in response to peripheral demand. Ly-6Chigh monocytes harbor the majority of 
cell-associated L. monocytogenes in the bloodstream. The mechanisms by which Ly-6Chigh 
monocytes are first enriched (migrated) in to the blood and then attracted to CNS during 
infection in not known yet. The phenotypic similarities from functional studies indicate 
that Ly-6Chigh monocytes are recent emmigrants from the bone marrow. Similarly, recent 
studies show that the phenotype of infected monocytes in the peripheral blood is similar 
in many respects to that of monocytes in the bone marrow suggesting that L. 
monocytogenes-parasitized monocytes originate in the bone marrow [68]. 
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It has been reported that CSF-1 knockout mice, which are depleted in monocytes and 
macrophages, show a reduced susceptibility to CNS infection by L. monocytogenes [69].  
 
1.3.1.3. Yersinia pestis  
Yersinia pestis, a gram-negative facultative intracellular bacterium, a causative agent of 
plague [70] and responsible for the Black Death in the Middle Ages, is primarily a rodent 
pathogen. It can be transmitted intradermally to humans through the bite of an infected 
flea. Y. pestis was responsible for the Black Death in the Middle Ages [71-73]. 
Y. pestis modulates its gene expression in a temperature-dependent manner, which is 
proposed to correspond to the adaptation to the two different environment, within flees 
and mammals [74]. As a result, Y. pestis grown on 26°C (temperature of flee) and at 37°C 
(temperature of mammals) targets DCs differently during in vitro infection [71,75,76]. The 
activation of DCs is mediated by the nature of Y. pestis lipid A, the immunostimulatory 
moiety of LPS. Upon transition from 26°C to 37°C, Y. pestis modifies the structure of its 
cell surface lipidA [77-79]. At lower temperatures the acyl transferase LpxP enables the 
biosynthesis of hexa-acylated lipid A. At 37°C, Y. pestis LpxP is presumably not produced 
and/or is inactivated and lipid A becomes mostly tetra-acylated. Hexa-acylated lipid A is 
recognized by TLR4 on DCs of rodents. In response, TLR4 induces IL-12p40 secretion and 
DC migration towards the lymph nodes [71]. DCs deficient in IL-12p40 fail to migrate 
toward CCR7 ligands upon exposure to bacterial stimuli [80]. Because the flea-borne 
bacteria (on rather low temperature, close to 26°C) need to reach and initiate infection of 
the lymph nodes, the ability of the hexa-acylated lipid A to induce DC activation and 
migration would allow efficient colonization of the lymph node. On the other hand, the 
temperature-sensitive induction of the tetra-acylated lipid A (already in lymph nodes) 
could allow the bacteria to remain and grow within the lymph node without stimulating 
immunity as it is not recognized by TLR4, thereby enabling development of very high 
bacteremia [71]. 
 
1.3.1.4. Borrelia garinii 
Spirochete Borrelia garinii is the causative agent of chronic Lyme disease. In many cases, 
the infection is limited to the skin and subsides even without treatment. However, in 
some patients, the bacterium evades the immune response and disseminates into various 
organs [55,81]. 
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B. garinii-stimulated DCs in vitro do not migrate effectively toward CCL19 and CCL21. The 
mouse model of B. garinii infection shows that the number of DCs migrating from the 
infection site to draining lymph nodes is only half that induced by the control, Escherichia 
coli, infection [81]. This inhibition is due to the significant down-regulation of CD38 and 
CCR7 expression in DCs [52], the two important factors, needed in DC chemotaxis and 
migration to lymph nodes. By impairing the migratory capacity of DC, B. garinii could lead 
to poor antigen presentation in the lymphoid organs and weaken the humoral immune 
response directed against it. This could account for some of the immune abnormalities 
seen in Lyme borreliosis. LC, DC of the epidermis, are present in Erythema migrans (EM) 
and Acrodermatitis atrophicans (ACA), the early and late skin manifestations of Lyme 
borreliosis, but the MHC II expression of these cells is decreased [81].  
 
1.3.1.5. Shigella flexneri 
The intestinal epithelium forms a barrier against microbial invaders. However, many food 
borne pathogens manage to overcome all four functional elements of the barrier: 
commensal bacterial flora, rapid turnover of the epithelium, innate immune responses 
and epithelial barrier integrity [82]. Shigella, while colonization of intestinal barrier hijacks 
the exfoliation of epithelial cells, one of the mechanisms of innate immune system 
against bacterial invaders. Shigella flexneri effector protain OspE, which is highly 
conserved among enteropathogenic E. coli, enterohaemmorhagic E.coli, Citrobacter 
rodentium and Salmonella strains, is delivered into the infected cell by means of Type 3 
secretion system (T3SS). It localizes to the focal adhesions and binds to integrin linked 
kinase (ILK). The ILK–OspE complex stabilizes integrin-containing adhesion sites by 
suppression of FAK phohosphorylation and increase of β1 integrin cell surface levels, thus 
reduces adhesion turnover and suppresses the detachment of infected cells from the 
basement membrane. OspE enables the pathogen to maintain an infectious foothold and 
bacteria evade being removed [83].  
Recently, it was shown that Shigella invasion and presumably injection of effectors in a 
bystander manner (absence of invasion into the cell cytoplasm) results in the inhibition of 
chemokine-induced migration of T lymphocytes. The interference with T cell trafficking 
mediated by the effector IpgD and was dependent on its phosphoinositol 4-phosphatase 
activity, which leads to hydrolysis of PIP2 with a resulting decrease of its pool at the 
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plasma membrane. In epithelial cells, IpgD-mediated PIP2 cleavage is responsible for 
dramatic morphological changes that lead to a decrease in membrane tether force 
associated with membrane blebbing and actin filament remodeling [84]. 
 
1.3.1.6. Salmonella typhimurium  
Another gastrointestinal pathogen using T3SS as a tool for manipulation of the host is 
Salmonella. The bacteria has a strategy preferentially to enter microfold (M) cells, a 
specialized epithelial cell types for sampling the intestinal antigens and transporting them 
to lymphoid cells in the underlying Peyer’s Patches (PP) [85,86]. The ability of Salmonella 
to survive inside of host cells is dependent on the SPI2-encoded T3SS that injects 
virulence/effector proteins into host cells. Some of the SPI2 T3SS translocated effector 
proteins have evolved to allow intracellular bacteria to subvert the bactericidal properties 
of macrophages and to create a specialized Salmonella-containing vacuole in which it can 
replicate. In addition, certain SPI2 secreted effectors can specifically interfere with DC-
mediated antigen presentation to CD4+ T cells [87,88], which are required to control 
bacterial replication within the host during a long-term systemic Salmonella infection [89]. 
The microarray analysis has revealed SseI, SPI2 T3SS effector of S. typhimurium, as a 
factor for long-term systemic infection in mice. Specifically, SseI blocks migration of 
macrophages and DC in vitro, by a mechanism that involves the interaction of SseI with 
the host factor IQGAP1, an important regulator of the cytoskeleton and cell 
migration. Salmonella reduces also DC migration in vivo in SseI-dependent manner. Thus, 
Salmonella uses SseI as a novel mechanism to manipulate host cell migration to dampen 
the ability of the host to clear systemic bacteria [90,91]. 
 
1.3.1.7. Chlamydia trachomatis 
Chlamydia trachomatis is an obligate intracellular bacterium responsible for the most 
cases of bacterial sexually transmitted infections. Three million new cases occur in the 
USA each year and the majority of cases (70%) are asymptomatic and not treated. 
Untreated, persistent infection or reinfection results in pelvic inflammatory disease, 
ectopic pregnancy and tubal infertility. In addition, chlamydial sexually transmitted 
infections enhance the transmission of human immunodeficiency virus and contribute to 
human papillomavirus-induced cervical neoplasia. 
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Prostaglandin E2 (PGE2) is induced by a chlamydial genital infection within epithelial cells. 
PGE2 is a well-known immune regulator that has both, stimulatory and inhibitory effects 
on the activation of DC subsets depending on the order of exposure to PGE2 and DC-
activating stimulants [92]. The PGE2-induced IL-10 secretion may promote but also inhibit 
the host response. Potentially, the enigma of the presence of increased DC migration, 
antigen uptake and the increase in IL-10 could be a means of promoting protective 
immunity while not generating destructive inflammatory responses [92]. 
 
1.3.2. Parasites subverting the migration of infected host cell 
1.3.2.1. Toxoplasma gondii  
Toxoplasma gondii is an obligate intracellular parasite of the phylum apicomplexa that 
causes chronic infections in up to one-third of the human population and in animals. 
When hosts, including humans, ingest T. gondii–containing cysts or oocysts, free T. gondii 
zoites are released in the gut lumen. They subsequently enter enterocytes, where they 
multiply and initiate the parasitic process. Enterocytes loaded with zoites secrete 
chemokines such as monocyte chemotactic protein 1 (MCP-1/CCL-2), macrophage 
inflammatory protein 1α, and β (MIP-1α and β/CCL3 and CCL4), as well as MIP-2/CXCL2, 
which recruit leukocytes in the lamina propria (LP) extravascular space. Parasites then 
disseminate to several distant tissues, including the brain, a major site supporting T. 
gondii progeny latency [93]. 
T. gondii infects a great variety of cell types including epithelial cells and blood leucocytes 
[94]. However, a preference for T.gondii to infect dendritic cells (DC) in vitro over other 
blood cells has been reported [95]. In vitro studies on human and murine DC revealed 
that active invasion of DC by Toxoplasma induces a state of hypermotility of infected cells, 
enabling transmigration of infected DC across endothelial cell monolayers in the absence 
of chemotactic stimuli. Infected DC exhibited up-regulation of maturation markers and 
co-stimulatory molecules. When migration of Toxoplasma-infected DC was compared 
with migration of LPS-stimulated DC in vivo, similar or higher numbers of Toxoplasma-
infected DC reached the mesenteric lymph nodes and spleen respectively. Adoptive 
transfer of Toxoplasma-infected DC resulted in more rapid dissemination of parasites to 
distant organs and in exacerbation of infection compared with inoculation with free 
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parasites. Toxoplasma is able to subvert the regulation of host cell motility and likely 
exploits the host’s natural pathways of cellular migration for parasite dissemination, 
during early, the acute phase of infection prior to the onset of protective host responses 
[6,96,97].  
 
1.3.2.2. Leishmania 
Leishmaniasis is one of the most diverse and complex of all vector borne diseases. At 
present, more than 20 species of Leishmania are known, which are primarily 
characterized by their tissue tropism (cutaneous, mucocutaneous and visceral infection). 
Humans, as well as small animals (e.g. rodents) and dogs, are natural reservoirs for the 
parasite. The parasite residing in the sand fly’s salivary glands is transmitted into the 
upper dermis of the skin. The promastigote (infectious life stage of the parasite) are 
rapidly phagocytosed by MΦs and transform into the obligate intracellular life form, the 
amastigote. During early silent phase of 4-5 weeks, the parasites replicate (up to 1,000-
fold) until finally more infectious amastigotes are released into the tissue from lysed MΦ. 
In the second phase, development of clinically evident lesions occurs coincident with the 
influx of inflammatory cells, including neutrophils, eosinophils and MΦ [98]. 
Although the MΦ comprise a major parasite reservoir in vivo and represent the primary 
host cell, Leishmania was shown to modify the motility and chemotaxis of various cells, 
including monocytes, polymorphonuclear neutrophils and phagocytes [99]. Agonist and 
antagonist effects of Leishmania upon cell migration and chemotaxis have been reported; 
this could be accounted for by the use of different strains of parasite and life cycle stages 
and dissimilar preparations of the parasite [100]. Products secreted by L. major 
promastigotes inhibit the motility of murine splenic DCs in vitro [99], and L. 
major lipophosphoglycan (LPG) inhibits migration of murine LCs [101]. Interestingly, 
after chronic infection with L. donovani in mice, there was IL-10-mediated inhibition 
of CCR7 expression and inhibition of DC migration from the marginal zone to the T-cell 
areas of the spleen, which may contribute to the development of visceral 
leishmaniasis [102].  
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1.3.3. Viral proteins interfering with the cell migration 
The HIV-1 (Human Immunodeficiency Virus-1) pathogenicity factor Nef, a 25-35 kDa 
myristoylated protein, interferes with cell motility by blocking chemoattractant-triggered 
actin remodeling. The effect of Nef on cell motility occurs independently of the cellular 
context ex vivo in Nef-expressing fibroblasts and HIV-1-infected primary T lymphocytes, as 
well as in zebrafish PGCs in vivo, and represents a conserved activity of Nef proteins from 
various HIV-1, HIV-2, and SIV (Simian Immunodeficiency Virus) strains. Mechanistic 
analyses demonstrate that inhibition of actin remodeling is mediated by Nef via its ability 
to associate with the cellular kinase Pak2, resulting in hyperphosphorylation and thereby 
inactivation of the evolutionary conserved actin depolymerization factor, cofilin [104]. 
The cell migration may even be modified differently by pathogen at different stages of the 
infection. As for SIV, DC mobilization facilitates virus spread to susceptible lymph node T 
cell populations, whereas depressed DC function during advanced infection promotes 
generalized immunosuppression [105]. 
Vaccinia, a close relative of variola virus, the causative agent of smallpox, was used to 
eradicate the disease during the past century [106]. Once cells are infected, vaccinia 
induces a number of major cytoskeletal changes, including the reorganization of 
microtubules, the loss of centrosome integrity and function, the loss of actin stress fibers, 
and the formation of actin tails [107]. In some cell types, vaccinia infection stimulates cell 
migration, loss of adhesion, and the formation of long cellular extensions, which make the 
cells appear as if they have a neuronal-like morphology [108]. The vaccinia virus-induced 
phenotype is dependent on the viral protein F11L [107,109]. The expression of F11L in 
uninfected cells results in a loss of actin stress fibers even in the presence of activated 
RhoA, which suggests that it inhibits signalling by this GTPase. This inhibition is the 
consequence of a direct interaction between F11L and RhoA, which prevents RhoA from 
interacting with its downstream effectors ROCK and mDia (formin homology protein). The 
region of F11L, involved in Rho binding, shares essential sequence homology with that of 
the Rho-binding motif of ROCK. Although in contrast to ROCK, F11L interacts with both 
GDP- and GTP-bound RhoA [107]. One can envisage that migration of an infected cell will 
increase the efficiency of virus spread because extracellular virus particles associated with 
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the plasma membrane, which are responsible for direct cell to cell spread, will come into 
contact with more neighboring uninfected cells than they would if the infected cell were 
static [109]. 
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1.4.  Bartonella spp. 
Bartonella species (spp.) are fastidious, gram-negative, facultative intracellular bacteria 
that are highly adapted to a mammalian reservoir host [110-112]. The list of Bartonella 
spp. is continuously increasing as new spp. are discovered. There are more than 22 
named and numerous unnamed or candidate species known for today [113]. 
Commonly, Bartonella infection in mammalian hosts is a prolonged period of intra-
erythrocytic bacteremia. Disease in the reservoir host, depending on the adaptation level 
to the host, varies from an asymptomatic or sub-clinical to clinical manifestations with 
low morbidity and limited mortality, as in case of human-specific B. quintana (Bqu) 
infection, or even to life-threatening severe hemolytic anemia associated with the 
human-specific infection by B. bacilliformis (Bba). [112].  
Besides erythrocytes, endothelial cells represent another major target cell type for 
Bartonellae. The phenomenon of host-restriction is determined by the specific capacity of 
Bartonellae to preferentially infect the erythrocytes of a given mammalian host, while 
endothelial cells may also become infected during incidental infection of non-reservoir 
hosts e.g., human infection by cat-specific B. henselae (Bhe), which may lead to bacillary 
angiomatosis lesions where bacteria are found in close association with proliferating 
endothelial cells [112].  
Bartonellae are mainly transmitted by arthropod vectors. Three species are known to 
infect and replicate in the digestive tract of their respective vectors: Bqu in body lice, Bhe 
in cat fleas and Bsch in the deer ked. The transmission strategy involves replication in the 
gut of the arthropod vector and excretion in the feces. There Bartonellae are thought to 
survive for several days [114]. The arthropods defecate while feeding with the blood meal. 
Thereby, the skin of the person (or animal) at the bitten area becomes contaminated with 
Bartonella-containing feces, where from then bacteria is inoculated in the derma of the 
reservoir host as the host scratches the skin and delivers the feces in underlying layers of 
the skin [115]. The primary infected cells in the derma or how the bacteria reach the 
blood system is not known yet. The blood stage life-cycle of Bartonella within the 
reservoir host was studied on the example Btr infection of rats by Schulein et al., 2001 
[116]. In this model intravenously injected wild-type Btr are rapidly cleared from the 
bloodstream. The blood stays sterile for at least three days. The Batonella-infected cell 
type within which the bacteria reside during these three days, where they survive and 
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replicate is yet unknown. On day four, Btr re-appears in the bloodstream, adhere to and 
invade erythrocytes. Within erythrocytes bacteria replicate for a few rounds without 
shortening the lifespan of the infected cells. Approximately every five days, a new wave of 
bacteria enters the bloodstream and invades the erythrocytes, sustaining the bacteremia 
for about ten weeks. The affinity of Bartonella for endothelial cells in vitro and the fact 
that these cells coat the blood vessels proposes the endothelial cells being another type 
of cells, other than erythrocytes, to be infected in vivo, where the bacteria hide the first 
three to four days, and from where they seed into the bloodstream.  
Bartonellae encode Type 4 Secretion Systems (T4SSs) as an adaptation tool for the 
establishment of host colonization. The Trw T4SS is essential for intra erythroytic 
infection of Btr as it was shown in an animal model [117-119], it mediates the host 
specific adhesion of Bartonella to erythrocytes in wide range of animals [120]. Another 
VirB/VirD4 T4SS represents a translocation system of Bartonella effector proteins – Beps 
into the endothelial and epithelial cells in vitro [121]. In vivo functional study of one of the 
effectors of Bartonella is presented in the next chapter of the thesis.  
Bhe translocates 7 Beps (BepA-BepG) into human endothelial cells. The Beps display a 
highly modular structure. At the C-terminus, each effector contains an approximately 140 
amino acid Bep intracellular delivery (BID) domain and a short positively charged tail 
sequence, both together compose signal for protein translocation via T4SS [121]. 
Additional BID domains are present in a subset of the Beps (BepE–BepG), which 
apparently are not required for protein translocation via VirB, but rather have adopted 
effector functions within the host cell [122]. BepG exclusively consists of four BID 
domains. Other evident domains are present in the N-termini of BepA–BepF. BepA, BepB 
and BepC contain a filamentation induced by cAMP (FIC) domain. BepD, BepE and BepF, 
each contain tandem-repeated peptide motifs in their N-terminal regions that resemble 
eukaryotic tyrosine-phosphorylation motifs (Figure 3) [123]. 
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Figure 3: a) The genetic structure of the virB/virD4/bep pathogenicity island. b) Model of 
the VirB/VirD4 T4SS machinery and modulary domain structure of BepA-G. Green boxes 
represent tyrosinecontaining sequence repeats resembling tyrosine-phosphorylation 
motifs (indicated by Y) or FIC (filamentation induced by cAMP) domain and blue the BID 
(Bep intracellular delivery) domain [124]. 
 
 
Several functional phenotypes are known to be induced by Beps. BepA has been shown to 
be targeted to the host cell plasma membrane and to inhibit apoptosis in HUVECs via 
elevating the cytosolic concentration of the second messenger cAMP [125]. BepA FIC 
domain was shown to adenylylate Hela cell extracts, however exact target proteins are 
unknown [126]. BepD and BepE are tyrosine-phosphorylated upon translocation in ECs 
(Guye, 2006) [122]. The c-Src tyrosine kinase (Csk) binds to a tyrosine-phosphorylation 
motif, which is very similar to the Csk-binding site in VE-cadherin, in the N-terminus of 
BepE. Also the protein tyrosine phosphatase SHP1/2 and adaptor proteins Grb2/7 bind to 
BepE and BepD in a tyrosine-phosphorylation-dependent manner [123]. Thus, BepE and 
BepD are hypothesized to provide docking sites for cell signalling proteins once 
translocated into the host cell [122-123]. BepG alone (in endothelial cells, ECs) or the 
combinations BepC/BepF and BepC/BepG (in ECs and Hela cells) are able to promote actin 
rearrangements required for invasome-mediated invasion. This process seems 
independent of the small GTPase RhoA but relying on Rac1 and Cdc42 involving the 
recruitment of the Arp2/3 complex (Figure 4) [127-129].  
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Figure 4: Invasome formation triggered by Bhe in HUVECs. 
Extracellular bacteria (arrowheads), intracellular bacteria residing within perinuclear 
endosomes (small arrows) and the bacterial aggregate within the invasome structure 
(large arrows) [126]. 
 
 
Despite those striking VirB/Bep-dependent changes in ECs (current in vitro model), the 
causal role and importance of the VirB/VirD4/Bep system in host invasion is unknown 
mainly due to the lack of appropriate animal models for Bartonella strains used for 
effector traslocation studies. The animal model with a consideration of natural host 
specificity and the route of transmission is needed for the studies about in vivo relevance 
of Bartonella effectors. These aspects are emphasized and addressed in next chapters of 
the thesis.  
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2.  Aim of the Thesis 
 
Started in December 2006, the primary aim of my thesis was to investigate Bartonella 
effector protein BepE in pathogen - natural host interaction interface. Following the 
establishment of the rat model of reservoir host with an intra-dermal delivery of bacteria, 
I identified an essential role of BepE in bacteremic colonization of the natural host. I then 
focused to elucidate the cellular basis how Bartonella fine-tunes the host manipulation by 
introducing BepE into the infected cells. For that, I have applied live cell imaging technics 
on in vitro infected endothelial cells with an emphasis on studding the interference of 
BepE with an impaired cell migration, potentially caused by other effectors proteins of 
Bartonella. Additionally, I aimed to reveal the primary infected cells in murine model of 
reservoir host infection to be able to translate the effect of BepE on the cells targeted by 
Bartonella in vivo.  
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Abstract 
The bartonellae is a family of gram negative, facultative intracellular, zoonotic bacteria 
that cause long lasting bacteremic infections of their various mammalian reservoir hosts. 
Bartonella uses a VirB type IV secretion system (T4SS) to translocate Bartonella effector 
proteins (Beps) into infected cells and thereby subverts host cellular functions. Here we 
functionally describe one of the effector proteins – BepE. An in vivo intra dermal (i.d.) 
model of rat infection with B. tribocorum (Btr) demonstrates a key role for BepE in the 
early stages of the infection in reservoir host. A Btr strain with two effector genes deleted 
(ΔbepDE) did not result in bacteremia, a hallmark of reservoir host infection. Single 
complementation with BepE from Btr (BepEBtr) or heterologous complementation with 
the two C-terminal BID (Bartonella intracellular delivery) domains of B. henselae (Bhe) 
BepE (BID1/2EBhe) was sufficient to enable Bartonella to reach the blood. The same 
dependency on the BID domains was observed in vitro. Primary endothelial cells (HUVECs) 
infected with a Bhe mutant lacking BepE (Bhe ΔbepE) underwent strong morphological 
changes. These changes developed as a result of disturbed rear edge detachment during 
cell migration, a phenotype we named cell fragmentation. Cell fragmentation was not 
observed when infecting HUVECs with the effector-free or T4SS-mutated (ΔvirB4) Bhe, 
and was restored by over expression of BID1/2EBhe in Bhe ΔbepE. Thus, BID1/2EBhe 
specifically interferes with the function of certain Beps secreted into the host cell during 
infection, thereby fine-tuning the manipulation of the host. Moreover, we were able to 
show the in vitro infectivity of primary mouse dendritic cells (DCs) with the host specific B. 
birtlesii (Bbi). This finding builds strong bases for future investigations to understand the 
nature and molecular mechanisms targeted by Beps as DCs may be the cell type primarily 
infected in derma and responsible to disseminate Bartonella into the blood. 
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Introduction 
A number of pathogenic bacteria have evolved a variety of virulence factors as tools to 
manipulate the host defence system to reach a replicative niche - a safe compartment to 
proliferate, that ensures easy transmissibility as well. All that enables bacteria to establish 
a long lasting persistent infection of the reservoir host [1]. Translocation of bacterial 
effector proteins into the host cell is one of the mechanisms to manipulate the host by 
interfering with its signalling pathways. The most prominent example of that is 
Helicobacter pylori (Hpy). More than half of the world population is infected with Hpy for 
their lifetime in the gastric mucosa but only <20% of them actually develop peptic ulcer 
disease. Together with other mechanisms and by secretion of a virulence factor VacA and 
type IV secretion (T4SS) apparatus dependent translocation of an effector protein CagA, 
Hpy succeeds to modulate the innate and adaptive immune responses of the host [1]. 
Another example is Brucella, an intracellular pathogen able to persist for long periods of 
time within the host and to develop a chronic disease. A functional VirB T4SS is required 
for Brucella to establish and maintain a persistent infection in an animal model [2]. 
Furthermore, this locus is required for intracellular survival in macrophages and HeLa cells 
by controlling the maturation of Brucella containing vacuole (BCV) into an organelle 
permissive for replication [3]. There are more examples; such as Legionella Dot/Icm T4SS 
which translocates a large number of bacterial effectors into the host cell in order to 
establish an intracellular replication in specialized vacuoles [4]; Salmonella SPI1 and SPI2 
type III secretion systems (T3SS) [1] and Shigella T3SS effectors play a critical role in 
invasion of non-phagocytic intestinal cells, for further dissemination and modulation of 
the host inflammatory responses [5,6]. 
Bartonella species are fastidious, gram-negative, facultative intracellular bacteria that are 
highly adapted to a mammalian reservoir host, within which the bacteria colonize 
erythrocytes as privileged host niche and develop long-lasting persistent infections [7-10]. 
The infections in the reservoir host range from an asymptomatic or sub-clinical (most 
animal-specific species) to clinical manifestations with low morbidity and limited 
mortality, such as human-specific B. quintana (Bqu) infections, or even to life-threatening 
disease, such as severe hemolytic anemia associated with the human-specific infection by 
B. bacilliformis (Bba) [9,11]. 
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Besides erythrocytes, endothelial cells represent another major target cell type for 
Bartonellae. The host-restriction is predominately determined by the specific capacity of a 
Bartonella species to preferentially infect the erythrocytes of a given mammalian host, 
while endothelial cells are known to become infected during incidental infection of non-
reservoir hosts e.g., human infection by cat-specific Bhe, which may lead to bacillary 
angiomatosis, lesions where bacteria are found in close association with proliferating 
endothelial cells [9,11,12].  
Bartonellae transmition is mediated by blood sucking arthropod vectors. The strategy 
involves replication of bacteria in the gut of the arthropod vector and excretion in the 
feces, with subsequent survival in the environment for several days [13]. The arthropods 
usually defecate when feeding and provide a source of local irritation that result in itching, 
followed by scratching and inoculation of Bartonella-containing feces into the derma [14]. 
Later, Bartonella is known to appear in the blood of reservoir host, invades erythrocytes 
and stays hidden from immune clearance for more than a year for some species. 
Nevertheless, which cells are infected before the onset of blood infection is not clearly 
understood yet [11,15]. 
Bartonellae evolved two T4SSs (Trw and VirB) while adapting to the wide range of 
mammalian host colonization. Both of them are essential for host interaction but at 
different stages of the infection cycle [15-18]. In more details, the Trw system seems to 
mediate the host specific adhesion of Bartonella to erythrocytes by binding to the cell 
surface with its manifold variants of pilus subunits [19,20], while the VirB system 
translocates a cocktail of evolutionarily related effector proteins, Beps, into the host cell. 
The Beps are encoded within the virB locus of Bartonellae (named BepA-G in Bhe). They 
have been evolved by duplication of an ancestral bep gene followed by their functional 
diversification and conservation of certain domains and motives [16]. All Beps have at 
least one BID domain (Bartonella intracellular delivery domain) and a positively charged 
tail in the C-terminus as a signal for translocation through the T4SS [21]. Beps have been 
intensively studied in vitro in the human endothelial cell infection model where they are 
able to subvert multiple physiological functions, such as actin dynamics, innate immune 
responses and apoptosis [21-25]. 
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BepE is one of the effector proteins, conserved within many species of bartonellae. Bhe 
BepE (BepEBhe) consists of 464 aa. The N terminus of BepEBhe, similarly to BepDBhe and 
BepFBhe, contains short repeated peptide sequences (EPLYA) with conserved putative 
tyrosine phosphorylation sites, similar to the EPIYA motive of Hpy effector CagA. BepEBhe 
has two BID domains in the C-terminal part [21]. The use of a model mimicking the 
incidental host invasion revealed some SH2 domain-containing eukaryotic interaction 
partners for BepEBhe. The kinase Crk, cellular phosphatases SHP1/2 and adaptor proteins 
Grb2/7 were identified to interact with the N-terminal phosphotyrosines of BepEBhe 
within a Csk like binding domain and an ITIM/ITSM (immunotyrosine inhibitory motif/ 
immunotyrosine switch motif) tandem of the effector protein [26]. These specific motives 
of BepEBhe and the described interaction partners suggest a molecular mimicry of ITIM-
containing receptors by bacterial protein. The fact that reservoir host infection is long 
lasting and displays almost no clinical manifestations indicates an efficient adaptation of 
Bartonella to the host niche and increases the interest to BepE to be investigated in vivo 
in the reservoir host infection model as a potential immune modulatory molecule. 
Bartonella-reservoir host interaction has been studied in a rat model developed by 
Schulein et al [15]. In this model, intravenously (i.v.) injected wild-type Btr are rapidly 
cleared from the bloodstream, which remains sterile for at least three days. On day four, 
the bacteria re-appear in the blood, adhere to and invade erythrocytes, where they 
replicate for few rounds without shortening the lifespan of red blood cells. Approximately 
every five days, a new wave of bacteria enters the bloodstream and invades the 
erythrocytes, sustaining the bacteremia for about ten weeks. This is in accordance with 
other animal models, such as B. grahamii (Bgr) i.v. infection of mice [27]. The affinity of 
Bartonella to endothelial cells in vitro and the fact that these cells coat the blood vessels, 
proposes the endothelial cells as another type of cells, other than erythrocytes, to be 
infected in vivo, where the bacteria hide the first three to four days, and from where they 
seed into the bloodstream. Rat i.v. infection model is a good model to study the long 
lasting colonization of blood by Bartonella. However, this model does not account for the 
first stages, the first interface of bacterial interaction with the immune system, as 
Bartonella is delivered directly into the blood stream. Recently, an intra-dermal (i.d.) 
infection model of Bbi has been introduced by Marignac et al [28], where the bacteria are 
inoculated in the derma of the ear. This model more likely reflects the natural route of 
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infection, mimicking the animal scratching a bitten area. Although not experimentally 
supported yet, the primary niche may comprise primary immune cells in the derma e.g. 
migratory cells such as dendritic cells which might assist the passage of bacteria from the 
site of inoculation to the lymphatic-blood system. 
In this study, we identify BepE as a critical bacterial factor for the early stages of 
Bartonella reservoir host invasion, prior the establishment of bacteremia. We found that 
BepE enabled the otherwise abacteremic - Btr ΔbepDE strain to reach the blood. This 
specific function was assigned to the C-terminal part of BepEBhe including the two BID 
domains. The same BID domains are interfering with the fragmentation phenotype of an 
infected endothelial cell; an in vitro observation induced by the other Beps as a secondary 
effect. Heterologus complementation of BepE loss-of-function phenotypes from different 
species either in vivo or in vitro strongly supports the idea that BepE has been evolved as 
a fine-tune mechanism to regulate host cell manipulation by Bartonella while colonizing 
its own reservoir mammalian host. Further, we show that Bartonella translocates the 
effector fusion protein into dendritic cells. Indicating that these cells could represent one 
of the cell-types infected in the animal before Bartonella reaches the blood system.  
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Results 
The intra-dermal rat infection model mimics the natural way of Btr 
infection 
Previous work gives some evidence that Bartonella effector protein BepEBhe could be a 
molecular mimicry of the immune inhibitory receptors. The work, based on in vitro 
studies in endothelial cell infection model, shows that BepEBhe is indeed translocated into 
the infected cell via T4SS and localizes to the plasma membrane (suppl. Figure 1). There it 
is tyrosine phosphorylated by cellular kinases at specific tyrosines within the motives that 
show similarity to Csk-like motive and ITIM/ITSM tandem of eukaryotic cells receptors 
[26]. Thus, BepE could potentially interfere with the host immune response during the 
establishment of Batonella infection by modulating the signaling pathways in immune 
cells. To assess the immunomodulatory capacity of BepE we decided to investigate it in 
vivo during the infection of the reservoir host. First we aimed to establish a suitable 
animal model, to closely mimic the natural way of transmission of Bartonella, taking into 
account the site of the infection and the specificity of Bartonella species to its reservoir 
host with its characteristic erythrocytic and asymptomatic long lasting infection. Thus, we 
decided to adapt the existing rat persistent intra venous (i.v.) infection model (established 
by Schulein et al, 2001) [15] to the mouse intra dermal (i.d.) model (Marignac et al, 2010) 
[28]. We introduced the intra dermal way of bacterial inoculation in the ear dermis of a 
rat using Btr for the infection. The rat is a susceptible host for Btr and at the same time a 
convenient animal model to monitor the development of blood infection in time course. 
The derma, the underling layers of the skin, is the first site where Bartonella is inoculated 
during the infection of the mammalian reservoir host via the feces of the arthropod 
vector and the place where Bartonella has to interact and infect other cell types than 
erythrocytes, the so far known cells to be infected in reservoir host. In contrast to this 
new model of infection, the previously established i.v. model, inoculation of Bartonella 
directly into the tail vein, is lacking an important stage – the cell-bacteria interactions that 
need to take place before bacteria enter the blood system.  
First we decided to compare the two routes of infection; i.d. versus i.v. and monitor the 
bacteremia of infected animals. As a first observation after infection, during the first few 
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days, the infected animals did not develop the redness or any other sign of inflammation 
at the site of inoculation on the ear or on the tail. To follow the time course of infection 
and the bacterial titer in the blood of the rats, the blood from tail vein of infected animals 
was sampled. Sodium-citrate supplemented blood samples were lysed by freezing at -
70℃ and serial dilutions of lysed blood in phosphate buffered saline (PBS) were plated on 
columbia agar plates with defibrinated sheep blood (CBA) to count the colony forming 
units (CFUs) per mL of blood. In the group of i.d. infected rats, Btr was first detected in 
the blood starting at day 7-8 post infection (dpi) and it reached around 106 bacteria /mL 
blood the next days (10 dpi). After 30 dpi bacterial titer started to decrease and in 10 
weeks of followed bacteremia Bartonella was almost cleared away from the blood system. 
This was in accordance with the consequences described previously in i.v. infection (by 
Schulein et al, 2001). Compared to i.v. infection a delay of about 4-5 days in time was 
observed until bacteria appeared in the blood of the ear inoculated animals. But once Btr, 
in i.d. infected animals, was already in the blood, it immediately reached almost as high 
titers as in case of i.v. infection (around 106-107 Bartonella/mL of blood). 
The delay in blood colonization in the i.d. infection route clearly corresponds to the way 
that Bartonella has to make before seeding into the blood system to be taken up by 
innate immune cells and probably transported to the lymphatic-blood system.  
 
Btr ΔbepDE loses the ability to colonize rat blood in i.d. infection 
Having an ideal persistent infection model for Bartonella in vivo studies, we decided to 
examine the role of BepE in the development of the infection. We therefore used a Btr 
strain that has an in frame deletion of bepD and bepE. BepDBtr and BepEBtr, both are 
homologs of BepEBhe and show high similarity in regards of having putative tyrosine-
containing motives and the BID domains (suppl Figure 2). 
Three groups of rats were injected intradermally either with PBS (mock) or with PBS 
solution containing Btr wild type (wild-type) or Btr ΔbepDE. Blood samples were collected 
from the tail vein with an immediate sodium-citrate supplementation at different time 
points up to 10 weeks (Figure 2). The blood was frozen to lyse red blood cells. Undiluted 
and serial dilutions of thawed blood in PBS were plated on CBA to enumerate colony 
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forming units (CFU) per mL of blood. Plotted graphs represent a time course for single 
infected animals from which bacteria were recovered at a given time point post-infection. 
Almost all Btr ΔbepDE-infected animals stayed abacteremic. In one case (one in 13 Btr 
ΔbepDE infected animals, combined results from 3 independent experiments) bacteria 
appeared in the blood with few days delay compared to rats infected with wild-type, but 
when the knockout strain actually reached the blood system it was as successful as wild-
type in colonization of blood showing high titers of bacteremia. 
In contrast to this observation, Btr ΔbepDE when directly delivered into the blood stream 
of rats by i.v. infection, behaved as wild-type (Figure 3.A). 
The clones retrieved from the rat tail vein blood where confirmed by PCR for the absence 
of the knocked out effectors to verify that the strain from the one animal that showed 
delayed colonization of blood was really Btr ΔbepDE and not the wild-type by miss 
handling (suppl. Figure.3). 
These data suggest that either one of the missing effectors in Btr ΔbepDE, BepDBtr or 
BepEBtr, or both of them, are of pivotal importance for Bartonella to colonize the 
reservoir host. Even more, there appears to be a cell type(s) in the dermis, other than 
erythrocytes, that is targeted by Bartonella. Btr ΔbepDE does not succeed within these 
cells, as the strain is not able to reach the blood.  
 
Expression of BepE alone in Btr ΔbepDE restores the bacteremia  
To further investigate the Btr ΔbepDE mutant strain in i.d. rat infection, complementation 
experiments were designed by expressing either both BepDBtr and BepEBtr, or single 
effector BepEBtr in trans on the plasmid under the control of their native promoter. The 
blood was sampled at two time points, at 10 (suppl. Figure 4) and day 16 dpi (Figure 3). 
Previous experiments showed that at day 10 wild-type Btr was able to reach high titer in 
the blood (Figure 1 and 2). The second time point was chosen to avoid missing any late 
seeding in rat blood as it was observed in a single case in Btr ΔbepDE infected animal. 
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As shown on Figure 3, pbepDEBtr complementation was able to restore the ΔbepDE-
phenotype to wild-type infection level and even the expression of BepEBtr alone was 
sufficient to complement the Btr ΔbepDE mutant.  
Moreover, heterologous complementation was performed with Bhe BepE. At protein 
level BepEBhe was well expressed in Btr (Figure 4.B). In rat infections BepEBhe was able to 
functionally replace BepEBtr and bring back the capability of Btr ΔbepDE mutant to 
colonize the blood stream (Figure 3). The Beps from Bhe and Btr are homologs of each 
other, BepE and BepD from both species share conserved tyrosine containing motives on 
their N-terminus and a C-terminal BID domain. The amino acid sequence similarity to 
BepEBhe for BepDBtr is 22,7%, while for BepEBtr it is slightly higher - 35,6% (suppl. Figure2). 
Plasmid complemented Btr strains from infected rats were checked for the stability of the 
plasmid. For this, the blood from infected animals was plated on CBA plates with/without 
plasmid resistance marker (suppl. Figure 5). From CFU numbers counted on both plates 
we could observe that during the colonization of red blood cells Bartonella tends to lose 
the plasmid encoded BepE and BepD, suggesting that there is no selection pressure any 
more in the blood to keep the plasmids.  
 
The BID domains of BepEBhe are sufficient to enable Btr to reach the blood  
To elucidate which part of the BepE molecule is responsible for the complementation of 
abacteremic phenotype of the Btr ΔbepDE, different mutant forms of BepEBhe were over 
expressed in the Btr ΔbepDE background and then the infectivity of those Btr strains was 
examined in the rat i.d. model. Two mutants of BepEBhe were chosen, one with all five 
tyrosines exchanged to phenylalanine (Y37,64,91,106,129->F) and the second, a truncated 
version of BepEBhe, with only the two BID domains and positively charged C-tail. Plasmids 
encoding the mutated BepEBhe where conjugated into Btr ΔbepDE and the expression of 
the BepEBhe protein was confirmed by western blotting (Figure 4.B). Heterologous 
complemented Btr ΔbepDE were administered in the ear of the rats. The Figure 4.A shows 
the CFUs per mL of rat tail vein blood of the animals infected with Btr ΔbepDE strains 
complemented with BepEBhe and BepEBhe mutants at 16 dpi. Similar results were obtained 
at 10 dpi (suppl. Figure 6). 
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The Btr strain with the tyrosine to phenylalanine exchanged mutant of BepEBhe could 
colonize the blood almost with the same titers as wild-type Btr and Btr ΔbepDE-pBepEBhe. 
The bacteremia was also observed for the strain that contained only the two BID domains 
and positively charged C-tail of BepEBhe. Thus, the tyrosine containing motives of BepEBhe 
and the N-terminal part seem not to be essential for Bartonella to reach the replicative 
niche in the reservoir host and the functional part of BepE in this system can be assigned 
to the BID domains. 
 
Infection of endothelial cells with Bhe ΔbepE (or ΔbepDEF) leads to the 
fragmentation of endothelial cells 
Another well-established model to study Bartonella is in vitro infection of human 
umbilical vein endothelial cells (HUVECs) with Bhe. The model was established in Prof. C. 
Dehio`s group to study the molecular mechanisms of Bartonella-incidental host cell 
interaction and the modulation of host cell signaling by Bhe effector proteins, including 
tumorigenic vasoproliferations [23-26,31]. Despite being a model for bacteria-incidental 
host interaction, HUVECs can serve as a model to study the cellular basis of the BepE 
effect observed in vivo. By this we change the host specificity and further findings that we 
may observe from HUVEC in vitro infection model, have to be validated on reservoir host 
cells that are infected by Bartonella in nature. However BepE could possibly have a dual 
function in both, incidental and reservoir host infection.  
To explore the BepE function in the infection of HUVECs, a Bhe mutant with an in-frame 
deletion of BepE (ΔbepE) was used. Compared to wild-type Bhe infection, late time points 
post infection showed striking changes in the morphology of the infected cells if infected 
with the ΔbepE mutant. ΔbepE-infected cells looked more elongated and often two parts 
of a cell remained connected only by a thin fiber-like structure, (as if two or more spots of 
the cells strongly adhered to the surface with focal adhesion complexes). Fragments of 
the cells without the nucleus were observed. We described this phenomenon as a 
fragmentation of the cell (Figure 5 and 6). A similar phenotype, even with a stronger 
effect, was observed when using a ΔbepDEF mutant of Bhe (Figure 5). 
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The fragmentation of HUVECs was followed and assessed in time with time lapse movies. 
For that we first generated HUVEC cells expressing mCherry LifeAct using Lenti viral 
vectors to visualize the actin cytoskeleton of the cells. Actin fluorescent cells were 
infected either with GFP-expressing Bartonella or Bartonella without fluorescence. 
Infected cells were monitored for 72 hours starting acquisition at 8 hours post infection 
(hpi). Infection with the Bhe mutants mentioned above showed a prominent phenotype, 
with the effect starting about 20-24 hpi. The Bhe (either wild-type or the mutant) infected 
cells formed filopodia and lamellipodia in the leading edge of the cell. The leading edge 
firmly adhered to the surface and the cell elongated. Next, the cell contracted and the 
rear edge detachment had to take place. Bhe ΔbepE (or ΔbepDEF) infected cells showed 
difficulties to detach from the surface while the cell was still actively moving forward, 
thus the cell became more and more elongated and at some point the thin connection 
between the cell body and rear broke, left a fragment behind. The cell body got smaller 
by continuous fragmentation. The fragments roamed on the substrate for a few hours 
and then came to a halt (for the movies of uninfected, wild-type Bhe, Bhe ΔbepE, and 
pBepEBhe complemented strain infected HUVECs see suppl. movie 1 on the CD attached 
and Figure 6). 
The fragmentation of infected cells was observed in wild-type Bhe infection as well but 
rather on late time points, starting after 48 hpi. 
 
BepEBhe alone is sufficient to complement the fragmentation phenotype of 
Bhe ΔbepDEF 
BepDBhe, BepEBhe and BepFBhe are the three Beps from Bhe harboring tyrosine containing 
motives and they show similarity to eukaryotic SH2-binding domains. Having these 
features all three of them could function as a mimicry of immune inhibitory receptors 
[62,63] and be involved in modulation of host signaling pathways. To test the hypothesis 
single complementation in trans was used for infections to see which Beps individually or 
in combination would be able to restore the fragmentation phenotype of the Bhe ΔDEF 
strain. 
3 - Results and Discussion 
Page | 49  
 
The phenomenon described above was not present in the case of Bhe ΔbepE or ΔbepDEF 
strains complemented with plasmid encoded BepEBhe. Neither BepDBhe nor BepFBhe 
without BepEBhe could functionally complement ΔbepDEF (Figure 7). 
 
The two BID domains of BepEBhe can interfere with the fragmentation of 
ECs 
As the inhibition of cell fragmentation could be linked specifically to BepEBhe, the next 
question to answer was whether it is associated to the N-terminal tyrosine containing 
motives or to the BID domains of BepEBhe. As described earlier, BepEBhe has two 
Bartonella Intracellular Delivery (BID) domains on its C-terminus and positively charged C-
tail. The BID domain together with the C-tail is a translocation signal recognized by the 
T4SS of Bartonella [21]. 
To understand which part of BepEBhe was responsible for the effect observed during the 
infection of HUVECs, BID1/2EBhe and BID2EBhe were expressed in Bhe ΔbepE (ΔbepDEF) 
(Figure 8 D) and then used to infect HUVECs. 
The BID domains (BID1EBhe and BID2EBhe) of BepEBhe show high similarity (pair wise 
identity is 53.3%) (Figure 8 B) and seem to be originated from a duplication event [15].  
The results of the HUVECS infected with BID domain complemented strains indicate that 
the effect observed by BepEBhe was indeed mediated specifically by the two BID domains 
of BepEBhe. Compared to the two domains expressed together the last single BID alone 
was not efficient to overcome the fragmentation (Figure 8 A and C). 
 
Fragmentation of ECs can be rescued by heterologous complementation of 
BepEBhe by BepEBtr, BepEBqu and BepHBgr 
Since both phenotypes connected to the BepE are related to the BID domains and we 
have seen that BepEBhe is functionally replacing the BepEBtr in the rat i.d. model, we were 
interested to see if Btr homologs of BepEBhe, BepDBtr and BepEBtr could also complement 
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the in vitro phenotype of the Bhe ΔbepE (ΔbepDEF). Next to Btr homologs we used 
heterologous complementation from Bqu (BepEBqu) and Bgr (BepHBgr). For the amino acid 
sequence similarity of BID domains of BepE homologs see suppl. Figure 2. Compared to 
other homologs the BID domain of BepDBtr, has less amino acid sequence similarity to the 
BID domains of BepEBhe.  
BepE from Btr (BepEtr), Bqu (BepEqu), and Bgr (BepHgr) were also able to complement the 
lack of BepE and infected HUVECs looked like wild-type Bhe infection. Amongst all the 
homologs of BepEBhe the BepDBtr was less potent to prevent cell fragmentation (Figure 
9.A and B). 
 
Ectopic expression of BepEBhe in ECs abrogates the cell fragmentation  
As all in vitro complementation experiments to rescue the fragmentation phenotype were 
based on expression of BepEBhe by plasmid in Bartonella, one could think induction of 
over expression as such may interfere with the secretion of the other Beps via T4SS 
actually responsible for the fragmentation of infected cells. Previous experiments showed 
that fragmentation is effector dependent (infection with a VirB/T4SS defective mutant of 
Bhe does not lead to fragmentation, suppl. movie 4, see CD attached), is not linked to 
BepABhe (Bhe ΔbepB-G strain is not leading to the disorganization of EC migration, data 
not shown), BepDBhe and BepFBhe but connected to the lack of BepEBhe (ΔbepDEF and 
single in trans complementation infections described above on Figure 7). Thus, three 
candidates are left BepBBhe, BepCBhe and BepGBhe that may affect the cells alone or in 
combination even with BepABhe.  
To prove that BepEBhe effect was specific to its function and not due to the passive 
outcome of being expressed in large amounts and consequently competing with other 
effectors for the translocation, we decided to transfect HUVECs by nucleofection method 
and express CMV promoter driven gfp-bepEBhe and then infect HUVECs with Bhe ΔbepE 
(ΔbepDEF). Using this approach we introduced BepEBhe into HUVECs in a T4SS-
independent way. Thus the other Beps from Bartonella would not be affected in the 
translocation. 
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GFP-BepEBhe ectopic expression was evaluated by FACS measurements and confocal 
microscopy (Figure 10.A). After 24h post tranfection more than 50% of the cells were 
expressing GFP-BepEBhe. 
Confocal microscopy of GFP-BepEBhe expressing HUVECs showed the localization of 
BepEBhe to plasma membrane with a clear exclusion of signal in the nucleus. In addition 
we observed a new phenotype for BepEBhe-expressing cells. They were rather flat and 
dispersed compared to untransfected or plain GFP-expressing cells (Figure 10.B). This 
phenotype was a specific effect of BepEBhe on primary endothelial cells but was not 
further investigated in this study. 
24 hours post transfection (hpt) HUVECs expressing GFP or GFP-BepEBhe were infected 
either with Bhe wild-type, or ΔbepE (ΔbepDEF). The infection was fixed at different time 
points and analysed by confocal microscopy (Figure 11). 
In control samples, where the plain GFP encoding plasmid was transfected, we still 
observed the fragmentation of green cells induced by Bhe ΔbepE (or ΔbepDEF, suppl 
Figure 8) infection (Figure 11). In contrast to that, the cells ectopically expressing GFP-
BepEBhe did not undergo fragmentation. Interestingly, within the same samples 
untransfected cells, the cells that did not express GFP-BepEBhe, underwent the 
fragmentation upon infection with knockout strains of Bhe. Similar results were observed 
when GFP-BepEBhe transfected cells were infected with Bhe ΔbepDEF, T4SS independent 
expression of BepEBhe also rescued Bhe ΔbepDEF-infected HUVECs from fragmentation 
(suppl.Figure 8). 
 
Bbi infects in vitro differentiated mouse BMDCs 
In vivo experimental data from rat i.d. model suggested a role for BepE in the 
establishment of infection at the early stages, prior to the invasion of blood. In addition, 
in vitro experiments showed that BepE was essential to inhibit the fragmentation of 
infected primary endothelial cells by interfering with the effect of other Beps. 
For a better understanding of BepE function in the infected cells and to further 
investigate the fragmentation phenomenon it is critical to reveal which cells are targeted 
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by Bartonella in vivo prior entering the blood. Assuming, that the bacteria are transmitted 
by arthropods from one reservoir host to another and the first site of infection is the 
derma, we can speculate that primary infected cells are innate immune cells in the skin. 
Neutrophils, dendritic cells and macrophages are the cells that should encounter the 
bacteria at the infected site. In the i.d. infection model Bartonella is detected in the blood 
at day 7. Bartonella has to migrate from derma to the blood system in order to establish a 
complete scenario of the reservoir host colonization. The candidate cell type for primary 
infected cell by Bartonella needs the capability to migrate from the site of infection 
towards the lymph nodes. Such a candidate is a dendritic cell. Dendritic cells (DCs) have 
high phagocytic activity in peripheral tissues and secondary lymphoid organs. The pH 
change in lysosomal granules is also rather moderate (7,2-7,4) compared to neutrophils 
(from pH8 sudden drop to pH5-4,5) and macrophages that have a very strong acidification 
of lysosomal lumens. DCs are professional Ag presenting cells to mount an effective 
immune response. They mediate the link between innate and adaptive immune 
responses and are “the decision makers” for the type of immune reactions [32,33]. These 
features make them attractive targets for some bacterial pathogens to highjack their 
functions and use them as Trojan horses during the invasion of their mammalian host [34]. 
To tackle the DCs as possible candidates for the primary infected cells we decided to 
assess the infectivity of bone marrow derived DCs in vitro. The rat intra dermal model is a 
very convenient persistent infection model of natural host to study pathogen-reservoir 
host interaction. It allows a good handling of the tail vein blood sampling in time course 
experiments of bacteremia. Thus, it is a perfect tool for the investigation of Btr and some 
in vitro characterized BepEBhe mutants. But on the other hand, in order to characterize 
and find primary infected cells in vivo we opted for the mouse model of i.d. infection [28]. 
Available reporter, Rosa 26-loxP-egfp Balb/c mouse line (from Matthias Mueller, Novartis 
pharma) adds the value of tools for such investigations. These mice have a floxed stop 
signal between β-actin promoter and egfp. At the same time, we already know that NLS-
Cre-BID fusion protein has the ability to be translocated by the T4SS of Bartonella into the 
infected cells [21]. Thus, we assumed that the infection with a Bbi strain (Bbi-Tn-cre) that 
encodes a NLS-Cre-BID fusion in the chromosome after transposon mutagenesis should 
recombine the floxed sites and allow GFP to be expressed. By this method any type of 
nucleated cells targeted by Bbi could be visualized by microscopy or flow cytometery.  
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In order to show in vitro infectivity of bone marrow differentiated dendritic cells (BMDCs) 
by Bbi bone marrow cells from, Rosa 26-loxP-egfp Balb/c mouse were cultured for 10 
days in the presence of Flt3 ligand. After differentiation, BMDCs were infected either with 
wild-type Bbi or Bbi-Tn-cre. Two days after infection GFP expression was detected by flow 
cytometry and inverted fluorescence microscopy in about 15% of BMDCs. The percentage 
of GFP-expressing cells increased up to 20% on day 3 (Figure 12).  
As most of the cells expressing GFP in the Bbi-Tn-cre infected BMDC culture were 
morphologically round and rather small in size, we wondered whether the GFP-signal was 
really specific and coming from live cells. Thus, we decided to check the viability of 
infected cells. In order to differentiate live and dead cells in infected DC co-culture the 
samples were stained with propidium iodide (PI). With that we confirmed that GFP-
expressing cells were PI negative, indicating that the plasma membrane integrity was not 
disturbed and thus the cells alive (Figure 12.B). 
 
Bbi infects both: plasmacytoid and conventional DCs in vitro 
Flt3L-dependent in vitro differentiation of dendritic cells allows the generation of large 
numbers of plasmacytoisd (pDCs) and conventional (cDCs) dendritic cells from bone 
marrow precursors [30]. However, BMDC culture is still a mixture of some “nondendritic” 
(CD11C-) cells and cells differentiated into DCs (~ 80-90% of cells are CD11c+) (Figure 13 
and 14). 
To further characterize the phenotype of Bbi infected cells, and to distinguish the 
subpopulations affected by Bartonella, the BMDC culture infected either with wild-type 
Bbi or Bbi-Tn-cre was stained with anti-CD11c antibodies either in combination with anti-
MHCIIb or anti-B220 antibodies. Anti-CD11c staining could confirm that GFP-expressing 
cells are differentiated dendritic cells (Figure 13.A and B). The most of the GFP positive 
DCs are expressing major histocompatibility complex IIb molecules (MHCIIb), meaning 
that infected dendritic cells have undergone maturation and have upregulated the 
antigen presentation system on the cell surface (Figure 14.A and B). With anti-B220 
staining two populations of GFP positive DCs can be distinguished. More than half of Bbi 
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infected cells were negative for the marker of pDCs, thus they represent conventional DCs 
(B220-) (Figure 14.A). In summary, Bbi is able to infect both: plasmacytoid and 
conventional DCs in vitro (Figure 14.C).  
The in vitro infectivity of BMDCs gave a strong basis to start the in vivo infections of Rosa 
26-loxP-egfp Balb/c mouse with Bbi-Tn-cre. With that we should be able to understand 
whether the DCs are infected in the primary infection site and serve as transporters of 
Bartonella from derma to lymphatic-blood system. In order to define an exact time of Bbi 
entry into the blood we characterized the time course of i.d. infection of Bbi in wild-type 
Balb/c mice. Although the number of bacteria per mL of blood did not exceeded more 
than 104, all infected animals developed blood stage infection and Bbi started to colonize 
blood at 5-6 dpi. (Suppl. Figure 9). Preliminary results from Rosa 26-loxP-egfp Balb/c 
mouse infected with Bbi-Tn-cre showed that in at 3 dpi CD11c+ GFP-expressing cells can 
be detected in the draining lymph nodes. Whether these DC migrated from the derma or 
whether they were infected by Bartonella in the lymph nodes cannot be answered at this 
time. To understand it better and to prove that impaired cell migration and fragmentation 
(in vitro observations) of infected cells have a relevance to in vivo infection of primary 
cells we need to perform i.d. infection of Rosa 26-loxP-egfp Balb/c mice with Bbi-Tn-cre 
ΔbepE next to Bbi-Tn-cre. By flow cytometry or histological analysis we should be able to 
observe the lack or decrease of GFP-expressing cells in draining lymph nodes of the mice. 
(For the homology of BepEBbi to BepEBhe and BepEBtr and the virB locus of Bbi see suppl. 
Figure 11). 
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Discussion 
The T4SSs of Bartonellae and their effector proteins have been evolved as a toolbox for 
the adaptation to and colonization of different mammalian reservoir hosts [16,35]. In 
most of the cases of Bartonella infection, the reservoir host develops a long lasting 
infection with only mild or no clinical manifestations [7-10]. This is a prominent example 
of a high degree adaptation, where bacteria are able to persist, multiply and transmit to 
another host, without compromising the host niche. In this study we report that 
Bartonella effector protein BepE is crucial for the establishment of reservoir host 
infection. Using the rat i.d. model of Btr infection we were able to mimic the natural way 
of Batonella infection by an arthropod. This allowed us to focus on an early stage of the 
host colonization where BepE revealed its important role in restoring bacteremia of Btr 
ΔbepDE-infected animals. This in vivo functionality of BepE was linked to its C-terminal 
part harboring the two BID domains. For the same BID domains we found in vitro that 
they interfered with the effect of other Bep proteins. These Beps have distinct functions 
within the host cell; however they may result in an impaired cell migration and 
subsequent fragmentation of the infected endothelial cells (ECs). Furthermore, based on 
our results, we suggest DCs, professional antigen presenting cells, as a candidate cell-type 
to be infected in vivo on the early stages of pathogen-host interaction. Summarizing, BepE 
could interfere with an impaired migration of the DCs once infected and help Bartonella 
to be transported as a cargo to the lymph nodes in order to disseminate further into the 
blood stream. 
Several of the known phenotypes of Bartonella infection are linked to the function of the 
VirB T4SS and its translocated effectors, such as activation of the transcription factor NF-
κB and stimulation of a pro-inflammatory response, protection from apoptosis and cell 
invasion by a unique cellular structure termed the invasome [22-25,31]. These morpho-
physiological changes upon infection with Bhe were observed in in vitro incidental host 
infection models, such as infection of human ECs. However, the incidental cases of human 
infection with Bartonella are rather too few to be a driving force for the evolution of 
bacteria to acquire special adaptation tools. Accordingly, we rather consider that T4SSs 
and Beps have been evolved within the process of reservoir host colonization.  
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This study describes for the first a role for Bartonella effector protein in vivo during 
reservoir host colonization. Previous animal model of rat i.v. infection with Btr 
(established by Schulein et al, 2001) did not reveal any function of Btr effectors in vivo. 
Compared to the proposed natural route of infection [13,14], the i.v. infection model 
lacks the early components of the reservoir host infection, the primary site of Bartonella 
inoculation – namely the derma and the first interaction with the innate immune cells. 
For that reason, we adapted the rat i.v. model to an intra-dermal infection route 
(Marignac et al, 2010). Our new rat i.d. infection model kept the host specificity for Btr 
and developed long-term infection with high bacterial burden in the blood (Figure 1). 
Most importantly, it mimicked the natural way of transmission, the scratching by animal 
after arthropod bite and the consequent inoculation of bacteria from the feces of the 
vector into derma. Thus differently from the i.v. route, the i.d. model enabled us to focus 
on an early phase of the infection prior bacterial entry into the blood stream and followed 
bacteremia. We observed 4-5 days delay of bacteremia in i.d. infected rats with wild-type 
Btr (Figure 1). This time delay could correspond to the way that Bartonella has to take, 
passing from derma (the site of inoculation) to the blood (the only place in the reservoir 
host in vivo where Bartonella has been detected) and to the possible interaction with the 
innate immune cells. Interestingly, at the site of infection, on the ear, the rats did not 
develop inflammation or any obvious signs of innate immune response. It is noteworthy 
to mention that Bartonella LPS is not recognized by TLR4 receptors. Moreover, there is 
evidence that the lipid A of Bhe and Bqu LPS is modified, has a cylindrical conformation 
and may act as a potent antagonist of TLR4, thus the production of proinflammatory 
cytokines in human monocytes is not induced [38,39]. In addition, human (a natural host) 
infection with Bqu is characterized with an over-production of the anti-inflammatory 
cytokine, interleukin-10 (IL-10) and an attenuated inflammatory cytokine profile [40]. All 
in all, this could explain the absence of inflammation at the inoculation site of Btr, 
indicating once more on how well bartonellae are adapted to their reservoir host.  
The Btr ΔbepDE in our rat i.d. infection model did not lead to the bacteremia of animals, 
while complementation with the two effectors, BepEBtr and BepDBtr or BepEBtr alone 
restored the blood colonization of i.d. infected animals (Figure 2 and 3). This observation 
shows that BepEBtr is sufficient to complement and is an essential factor for the 
establishment of the infection, enabling Bartonella to reach the blood. This statement is 
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also supported with a single case of Btr ΔbepDE i.d. infection, where the BepD/BepE 
effector-less bacteria appeared in blood on day 16 post infection. However, when the 
bacteria actually reached the blood, bacteremia developed with the same titers as 
observed for the wild-type Btr infection (Figure 2), indicating that the effectors are rather 
needed in the early stage but not to maintain the infection in blood steam any more. At 
the same time, we saw that Btr ΔbepDE was bacteremic when directly delivered into the 
blood stream by the i.v. route (in contrast to i.d.) and the plasmid complementation 
restored the bacteremia in i.d. infection. These observations prove that the abacteremic 
phenotype of the Btr ΔbepDE in i.d. infected animals is not because a consequence of any 
attenuation of the strain after genetic manipulations for in-frame deletion of the effector 
proteins. Further supporting the role of BepEBtr prior to seeding of the bacteria into the 
blood, plasmid-complemented Btr ΔbepDE strains tended to lose the effector encoding 
plasmid in the blood. Less than half of the Bartonella pool contained the plasmid at day 
10. The percentage of plasmid-containing bacteria in blood decreased gradually in time 
(suppl. Figure 5), suggesting that there is no more selection pressure to maintain the 
effector-encoding plasmids during erythrocyte invasion. Following the same tendency, 
the virB4 and virD4-encoding plasmids of Btr are lost in the rat i.v. infection [18]. These 
plasmid segregations indicate that VirB T4SS is no longer essential for the erythrocyte 
invasion. All these data suggest that Bartonella is targeting a cell type in vivo, apart from 
erythrocytes, where it survives in the presence of BepEBtr and is able to further develop 
the infection with bacteremia, while the Btr ΔbepDE strain does not succeed to reach the 
blood. 
Bartonella effectors are known to have functional redundancy, the ability of structurally 
different elements to perform the same function or yield the same output [41]. Bhe is 
capable of triggering invasome formation on epithelial and ECs in two different ways, by 
BepCBhe/BepFBhe or BepGBhe-triggered actin cytoskeleton rearrangements [24]. The other 
three effectors, BepDBhe, BepEBhe and BepFBhe bare N-terminal putative tyrosine-
containing motives (ITIM/ITSM). Within these motives they interact with SH2 domain-
containing cellular partners in tyrosine phosphorylation dependent manner. These 
interaction partners are identical for BepDBhe and BepEBhe: Csk, Shp1/2, and Grb2/7 [26]. 
Moreover, in addition to the BID domains, these phospho-tyrosine motives are present in 
both, BepEBtr and BepDBtr but whether these two effectors have a redundant effect on 
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the restoration of bacteremia in vivo or whether BepDBtr is not involved in this process 
has not been addressed in this study. 
Heterologous complementation of Btr ΔbepDE with pBepEBhe and the subsequent 
bacteremia observed in rats speak for a conserved function of BepE between different 
species of bartonellae (Figure 3). Surprisingly, the BID domains of BepEBhe were sufficient 
to restore the bacteremia but the ITIM/ITSM tandem containing N-terminal part did not 
reveal an essential role (Figure 4). Thus, we were not able to support the hypothesis of a 
molecular mimicry of immune inhibitory receptors by BepEBhe [26]. However, we suggest 
that this may still be valid and has to be addressed again in “primary niche” cells. There 
was a slight decrease in the bacterial burden in blood when complementing with the two 
BID domains of BepEBhe compared to BepEBhe wild-type. This could be explained with 
some conformational role of N-terminal part of BepE for the full length protein. The N-
term might plays a role even together with other effectors not showing phenotype strong 
enough to be visible in our in vivo model by looking only at blood colonization. It is also 
noteworthy to mention that the number of bacteria (107 bacteria) that we take for the i.d. 
inoculation is by far a lot compared to what in nature could be delivered via the feces of 
the arthropod. Thus, by providing such an amount of inoculum we may lose the 
phenotype of BepE N-term. It is important to mention that most of the phenotypes 
associated with the Beps of Bhe are related to the BID domains. This conserved domain is 
present in at least one copy in all Beps as it constitutes the secretion signal for the 
transport via the VirB T4SS. Interestingly, the BIDs seem to be capable of adopting various 
functions in the host cell [16]. The anti-apoptotic effect of BepABhe is delineated to the 
BID domain of this protein [25]. BepFBhe acts as a GEF (guanine nucleotide exchange 
factor) protein for Cdc42 and this activity is also contained in the two BID domains, 
BID1FBhe and BID2FBhe (M. Truttmann, Thesis work, 2010).  
Using the rat i.d. model we were able to clearly demonstrate that BepE, more specifically 
the BID domains of BepEBhe, are essential for the development of a complete picture of 
Bartonella infection of the reservoir host. These domains enable bacteria to reach the 
replicative niche – invading erythrocytes and persisting for long times without obvious 
clinical manifestations of disease and without harming their natural host. The same in 
vivo model revealed that BepE is essential before Bartonella seeds into the blood; 
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proposing that there are other cell type(s) than erythrocytes infected in the animal. 
Within these cells Btr ΔbepDE strain is not able to succeed in the absence of BID domains 
of BepE. To address the cellular basis and what happens with the infected cells in the 
absence of BepE, we decided to move to a well-established in vitro infection model, 
infection of primary endothelial cells, HUVECs, with Bhe. 
HUVECs infected with Bhe ΔbepE strain showed a sticking phenotype. The infection with 
this strain affected cell migration process. As described elsewhere, cell migration is a 
coordinated cellular movement that requires a series of repetitive, integrated processes. 
The first step is the forward protrusion of lamellipodia and filopodia, which is dependent 
on extensive remodeling of the actin cytoskeleton. Next, attachment at the leading edge 
occurs with focal adhesion complexes. After the formation of new adhesions, the cell 
undergoes actomyosin-dependent contraction to pull the cell body forward. Once the cell 
body contracts, attachments at the rear of the cell are released so that the cell can move 
forward [42,64-70]. HUVECs are characterized with a random migration in cell culture 
(suppl. movie 1, see on CD attached). The wild-type Bhe infected HUVECs (similarly to 
uninfected ones) develop through all the four steps of cell migration described above. 
However, the cell migration looked different when HUVECs were infected with Bhe ΔbepE, 
cells could not detach at the rear and underwent fragmentation (Figure 5 and 6, suppl. 
movie 2, see CD attached). The similar but even stronger phenotype was observed when 
infecting HUVECs with Bhe strain lacking the three effectors: BepDBhe, BepEBhe and 
BepFBhe (Figure 5), the three Beps with putative tyrosine-containing motives on the N-
terminal part and the BID domains with positive C-term as a bipartite signal for 
translocation via T4SS [21]. We assume that the fragmentation of infected HUVECs is 
clearly T4SS dependent, as the infection with ΔvirB4 (defective VirB T4SS) did not lead to 
the fragmentation of ECs (suppl movie 5, see CD attached). Even more, the induction of 
the phenotype is connected to the translocation of Beps, BepABhe can be ruled out as the 
fragmentation was not observable when infecting cells with a Bhe ΔbepB-G strain (data 
not shown). Thus, only three candidates left to be responsible for the impaired cell 
migration: BepBBhe, BepCBhe and BepGBhe, or different combinations of them even with 
BepABhe or with any unknown factor of Bartonella. BepDBhe, BepEBhe and BepFBhe need to 
be deleted to see the fragmentation; hence they do not induce but may rather interfere 
with the process.  
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Further, we showed that over-expression of BepEBhe in either Bhe ΔbepE or ΔbepDEF 
background can rescue infected ECs from fragmentation. This was explicitly characteristic 
for BepEBhe as BepDBhe and BepFBhe could not interfere with Bhe ΔbepDEF-induced the 
cell fragmentation (Figure 7). In addition, T4SS-independent expression of BepEBhe into 
infected HUVECs indicated that BepEBhe is actively interfering with the cell fragmentation 
process due to the specific function and not by stressing Bhe to produce BepE in large 
amounts and block the translocation of the rest of the Beps into the target cell, the Beps 
that may even be responsible for the fragmentation (Figure 11, and suppl. Figure 8).  
Similarly to the in vivo phenotype, the function of BepEBhe in vitro was assigned to the BID 
domains and not to the N-terminal part of the protein. The two BID domains of BepEBhe 
are similar with 53,3% of pair wise aa identity of (Figure 8.B). A single last BID domain was 
not enough to protect cells from fragmentation, but two together do interfere with the 
process (Figure 8.A and C). It may be that the last BID domain, BID2EBhe, together with the 
C-tail maintained a bipartite translocation signal via T4SS, while the BID1EBhe acquired a 
new function to rescue infected cells from the fragmentation. However, this statement 
needs to be proven further by the single BID1EBhe expression in Bhe ΔbepE or ΔbepDEF-
infected HUVECs. 
How the cell fragmentation develops or the molecular mechanism used by BepEBhe to 
interfere with the processes are currently unknown, but we assume that the focal 
adhesion turnover at the rear edge of the migrating cells is impaired. Cell adhesion and 
migration require many spatio-temporally integrated components, all of which must be 
quickly and precisely regulated [42]. Focal adhesion kinase (FAK), GEFs for Rho and the 
Rho effector, Rho kinase II (ROCKII) are crucial for the regulation of adhesion turnover and 
rear edge retraction. Functional interferences to one of these components can potentially 
lead to the disturbed migration of the cell [43,44]. Inhibition of RhoA activity by its 
inhibitor, C3, leads to a strong morphological change of migrating monocytes, with 
frequent polarization and long tails trailed behind the cell body [45]. A phenotype that is 
very similar to the early stage of the cell fragmentation observed in ΔbepE or ΔbepDEF-
infected HUVECs. Rho GTPases, regulate cytoskeletal dynamics and migration in many 
diverse cell types. RhoA signaling was shown to be coordinated at both, the leading edge 
and at rear during T cell migration. It is predicted that RhoA activation is independently 
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regulated by different GEFs in response to the unique microenvironments in each cellular 
region. As an example, GEF-H1 localization is restricted to the rear of crawling and 
transmigrating T cells, suggesting that its function is to activate RhoA locally at the back of 
migrating cell [46]. Interestingly, we have evidence that BepCBhe may be the effector 
inducing the cell fragmentation, next to its distinct function during invasome formation. 
This hypothesis is based on a fact that GEF-H1 can be pulled down together with BepCBhe 
from Bhe-infected cells (R. Conde, unpublished), indicating an indirect (or even direct) 
effect of BepCBhe on the local regulation of RhoA activity at the cell rear. To explain how 
the cell fragmentation develops we suggest the following possibilities. Invasome 
formation largely modifies the actin dynamics, inducing its rearrangements. Massive 
recruitment of GEF-H1 by BepCBhe to the invasomes, may result in local depletion of RhoA 
activity at the rear of migrating cell and thus leading to the impairment of focal adhesion 
turnover. Another important factor recruited by BepCBhe/BepFBhe mediated invasome 
formation is cofilin [47], the actin depolymerization and remodeling factor [48,]. Yet not 
very clear but there are some indications about an indirect regulation of cofilin by RhoA 
[49,50]. We propose that during migration of the infected cells cofilin may be sequestered 
from the rear edge of the cell, as it is involved in invasome formation. Many isoforms of 
tropomyosin are known to compete with ADF/cofilin proteins for binding to the actin 
filaments and stabilize the F-actin [51], thus stabilization of the actin filaments and 
impairment in depolymerization, could lead to the trouble of rear edge detachment, 
disturbed cell migration and subsequent fragmentation. This hypothesis is also supported 
by the observations from the cofilin knockdown in metastatic cancer cells. Cofilin 
deficient cells have rear detachment problem, forming thin elongations in the back side of 
the cells while moving forward [52]. These data strengthen our idea that the cell 
fragmentation phenomenon is induced by the Bep(s) involved in the invasome formation 
as a secondary effect and BepEBhe serves as a tool that interferes with this secondary 
effect. 
We suppose that when infecting the reservoir host with Btr ΔbepDE, in vivo 
fragmentation or impaired migration of an infected cell is likely happening as well. The 
derma, where Bartonella is inoculated during the natural host infection, is the site where 
bacteria have to interact and infect innate immune cells. The Btr ΔbepDE cannot reach 
the replicative niche within the erythrocytes. The bacteria are cleared by the immune 
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system before appearing in the blood, (or reside in a niche for a long time and we just do 
not see it) this may be a result of a fragmentation of the primary infected cells in the 
derma or on the way to the lymphatic-blood system. The fragmented cells may be better 
recognized by neighboring immune cells and consequently degraded. As a result Btr 
ΔbepDE is exposed effectively to the innate immune system and is cleared on the early 
phase of the infection. DCs may serve as one of the candidate cell types for yet unknown 
“primary niche” of Bartonella infection. Skin migratory DCs participate in defense 
mechanisms against pathogens that gain access to the epidermis or dermis as a 
consequence of pathogen-specific skin invasion, skin lesions, or inoculation by insects. In 
steady state skin migratory DCs include immature epidermal DCs, langerhans cells (LCs) 
and immature dermal DCs [53]. The immature DCs are characterized with high phagocytic 
activity. They constantly sample the environment as sentinels for foreign antigens (Ag). At 
the same time, dendritic cells exhibit limited degradation of phagocytosed antigens, 
which in general favor efficient antigen presentation to T lymphocytes. Thus as 
professional antigen presenting cells, DCs play a central role in activation of resting T cells 
and initiation of primary and memory immune responses to build an effective defense 
mechanism and clear the organism from pathogens. While the other phagocytes 
neutrophils and macrophages, possess high destructive capacity of the cargo and serve as 
antigen non specific first line of defense [30,31]. Once become activated by taking up the 
Ags, DCs start directional migration towards the draining lymph nodes, upregulate MHC 
class II and costimulatory molecules in order to present the Ags to naive T cells within the 
peripheral lymph nodes and initiate the effective adaptive immune responses [36, 37]. On 
the way to lymph nodes DCs may serve as transporters of bacterial cargo and this in turn 
may be used by the bacteria as a strategy to disseminate in the host organism. These 
features of DCs make them attractive to be targeted and hijacked by different pathogens, 
with subsequent modulation their immunogenic responses with tolerogenic. Bordetella 
bronchiseptica T3SS is required for increased migration of respiratory DCs to secondary 
lymphoid tissues, where they stimulate immunosuppressive/tolerogenic immune 
responses with IL-10/low IFN-γ profile that contribute to long-term colonization of the 
murine respiratory tract [34].The maturation, antigen presentation properties and 
cytokine profile of infected DCs are negatively regulated by Yersinia enterocolitica Yops 
[54,55] and Brucella Omp-25 or Btp1 [56-58]. DCs are another target cells (next to 
macrophages) for Salmonella. It infects lamina propria DCs and with the virulence factor 
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spvB (and possibly spvC) contributes to the alternative (TTSS-1 independent) pathway of 
gut inflammation by enhancing the transition from CD11c+ to CD11c− host cell types and 
pathogen loads in the cecal mucosa [59].  
We further wanted to investigate the impaired cell migration and fragmentation 
phenomenon in Bartonella-reservoir host, to understand whether these processes are 
affected in primary infected cells as well. The reporter tool, Rosa 26-loxP-egfp Balb/c 
transgenic mice and the infection of BMDCs from these mice with Cre-BID fusion-
expressing mouse specific Bbi (Bbi-Tn-cre) gave the first evidence in vitro that DCs could 
represent one of the primary cells targeted by Bartonella in the reservoir host (Figure 12 
and 13). We confirmed that GFP expressing BMDCs were alive; nevertheless those cells 
looked small in size and round in shape. The explanation why the GFP positive cells are 
small and having so different shape from the rest of the cells can be different: the 
infected cells undergo activation and morphology change; or the intensity of GFP in GFP 
positive cells is rather low and only the cells that are rounded up and thus have 
concentrated GFP signal are detectable by microscopy, and not the weaker expressors 
(Figure 12.A and B). With a phenotypical staining we could confirm that infected cells 
were indeed DCs, expressing CD11c and Bbi translocated the fusion effector in both of the 
subpopulation of BMDSc, plasmacytoid and conventional DC without any obvious 
preferences (Figure 14). In addition, we have preliminary evidence from Bbi-Tn-cre i.d. 
infected Rosa 26-loxP-egfp Balb/c transgenic mice, where we found GFP expressing cells 
in the draining lymph nodes. These results give a strong basement to our hypothesis that 
DCs are one of the cell types infected by bartonellae in vivo which carry the bacteria from 
primary infection site to the blood stream. 
Taking together, in this study we provide the first understanding of the role of the 
Bartonella effector protein in vivo. BepE is an essential factor evolved by Bartonella to 
develop infection of a reservoir host. More specifically, we think DCs are one of the cell 
types infected prior blood stage infection where the BepE interferes with the function of 
other Beps and fine-tunes the host manipulation. As a result Bartonellae evade the 
clearance from primary immune system prior reaching the replicative niche in the blood, 
where it multiplies, stays hidden from host defense system and is safely transmitted 
further by arthropod vectors to another mammalian host. Further animal experiments are 
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needed to confirm the migration of primary infected cells from the derma to lymphatic-
blood stream. To prove our hypothesis about Bartonella dissemination by DCs and the 
role of BepE in this process, next to wild-type Bbi-Tn-cre, Bbi-Tn-cre ΔbepE has to be used 
for infection of mice and BMDCs in vitro, which may reveal the impaired migration of 
primary immune cells. 
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Materials and methods 
Ethics statement 
Animals were handled in strict accordance with good animal practice as defined by the 
relevant European (European standards of welfare for animals in research), national 
(Information and guidelines for animal experiments and alternative methods, Federal 
Veterinary Office of Switzerland) and/or local animal welfare bodies. Animal work was 
approved by the Veterinary Office of the Canton Basel City on June 2003 (licence no. 
1741). 
 
Bacterial strains and growth conditions 
The bacterial strains used in this study are listed in Table 1. Bartonella spp were grown on 
Columbia agar plates containing 5% defibrinated sheep blood (CBA plates) at 35°C and 5% 
CO2 for 2-3 days. Strains Btr RSE149 [15] and Bhe RSE247 [21] spontaneous streptomycin-
resistant strains and Bbi PEE0261 served as wild-type Btr, wild-type Bhe and wild-type Bbi 
respectively in this study. When indicated, media were supplemented with 30 μg/ml 
kanamycin, 100 μg/ml streptomycin, 10 μg/ml gentamicin, and/or 500 μM isopropyl-β-D-
thiogalactoside (IPTG, http://www.applichem.de). E. coli strains were cultivated in Luria-
Bertani liquid medium (LB) or on Luria-Bertani agar on plates (LA) at 37°C overnight. 
When indicated, media were supplemented with 50 μg/ml kanamycin, 200 μg/ml 
ampicillin, 20 μg/ml gentamicin, 500 μM IPTG, and/or 1 mM diaminopimelic acid (DAP). 
 
Conjugation of Bartonella-expression plasmids into Bartonella 
Conjugation of plasmids from the E. coli dap– mutant b2150 (Dehio and Meyer, 1997) 
into Bartonella spp. was done by triparental mating in the presence of helper plasmid 
pRK2013 as described previously (Dehio et al., 1998). 
 
DNA manipulations 
Plasmids used in this study are listed in Table S1, primers are listed in Table 2. 
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Plasmid for expression of MYC-Beps 
By excising full length bepE from pPG105 with NdeI and inserting it into the respective 
sites in pPG180, the MYC-BepEBhe expressing vector, pPG185, was constructed. The 
vector expressing the two C-terminal BID domains of BepEBhe without the N-terminus, 
pPG172, was constructed by PCR amplifying a fragment of 1 kb from pPG105 with the 
primers prPG148 and prPG149. After digesting the fragment with NdeI, it was inserted in 
the respective site of pPG180. 
The vector expressing the last C-terminal BID domain of BepEBhe, pRO104, was 
constructed by PCR amplifying a fragment of 576 bp from pPG105 with the primers 
prRO030 and prPG101. The PCR product was subcloned into pSC-B blunt end cloning 
vector (Strata clone blunt PCR cloning kit) yielding pRO010. After digesting the pRO010 
with NdeI, it was inserted in the respective site of pPG180. 
The vector expressing the BepEBqu, pRO105, was constructed by PCR amplifying a 
fragment of 1502 bp from boiled colony of Bqu RSE356 with the primers prRO033 and 
prRO034. The PCR product was subcloned into pSC-B blunt end cloning vector (Strata 
clone blunt PCR cloning kit) yielding pRO011. After digesting the pRO011 with NdeI, it was 
inserted in the respective site of pPG180. 
The vector expressing the BepHBgr, pRO105, was constructed by PCR amplifying a 
fragment of 831 bp from boiled colony of Bgr CHDE142 with the primers prRO035 and 
prRO036. The PCR product was subcloned into pSC-B blunt end cloning vector (Strata 
clone blunt PCR cloning kit) yielding pRO013. After digesting the pRO013 with NdeI, it was 
inserted in the respective site of pPG180. 
 
Plasmid for expression of proteins without an epitope tag 
For constructing vector pPG110 expressing native proteins, the oligonucleotide primers 
prPG90 and prPG91 were used to amplify a 0.4 kb fragment from pRS40 template DNA. 
Using flanking SacI sites the generated fragment was inserted into the corresponding site 
of pRS40. Next, a 1.67 kb fragment containing the complete bepD gene and an N-terminal 
MYC tag was amplified using oligonucleotide primers prPG141 and prPG145 and 
chromosomal DNA of RSE247 as template. Using flanking NdeI-sites the amplified 
fragment was ligated into the corresponding site of pPG110, yielding pPG184. The empty 
3 - Results and Discussion 
Page | 67  
 
MYC tag expression vector, pPG180, was generated by cutting out bepD with NdeI from 
pPG184, and religating the vector.  
 
Construction of in-frame deletions 
In-frame deletion mutants of Btr RSE149 and Bhe RSE247 were generated by a two-step 
gene replacement procedure as described (Schulein & Dehio, 2002; Schmid et al., 2004) 
[18,22]. The basic mutagenesis vector pTR1000 was described before (Schmid et al., 2004) 
[22]. All mutagenesis plasmids harbour a cassette with the flanking regions of the in-
frame deletion in the gene(s) of interest. This cassette was generated from two PCR 
fragments amplified from chromosomal DNA of Btr RSE149 or Bhe RSE247 as template, 
either by megaprime PCR or by conventional cloning. 
pFS20 used for generating a Btr ΔbepDE in-frame mutant was constructed as follows. 
Oligonucleotide primers prFS09 and prFS10 amplified fragment 1 (736 bp, containing 356 
bp of 5` end of bepCBtr) and prFS11 and prFS12 amplified fragment 2 (665 bp, containing 
345 bp of 3` end of bepHBtr). Both fragments were combined by megaprime PCR with 
oligonucleotide primers prFS09 and prFS12, resulting in a fragment of 1.64 kb carrying an 
in-frame deletion in bepDEBtr. By using flanking BamHI sites, the fragment was inserted 
into the corresponding site of pTR1000, yielding pFS20. The use of pFS20 for gene 
replacement in RSE149 resulted in the Btr ΔbepDE mutant FS150. 
Construction of the in-frame mutant Bhe ΔvirB4 has been described previously (Schmid et 
al., 2004) [22]. 
Construction of the in-frame mutant Bhe ΔbepD, Bhe ΔbepE, Bhe ΔbepF has been 
described previously (Scheidegger et al., 2009) [60]. 
pPG163 used for generating a Bhe ΔbepDEF mutant was constructed as follows. 
Oligonucleotide primers prTR041 and prTR051 amplified fragment 1 (853 bp, containing 
321 bp of 5` end of bepCBhe) and prTR055 and prTR056 amplified fragment 2 (665 bp, 
containing 345 bp of 3` end of bepGBhe). Both fragments were combined by megaprime 
PCR with oligonucleotide primers prTR041 and prTR056, resulting in a fragment of 1.67 kb 
carrying an in-frame deletion in bepDEFBhe. By using flanking BamHI sites, the fragment 
was inserted into the corresponding site of pTR1000, yielding pPG163. The use of pPG163 
for gene replacement in RSE247 resulted in the Bhe ΔbepDEF mutant PGE26. 
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Chromosomal integrations 
Suicide vector pPG612 for chromosomal integration for Bhe was constructed in 3 
sequential steps. 
On the first step oligonucleotide primers prTR041 and prTR042 amplified fragment 1 (0.83 
kb) and prTR043 and prTR044 amplified fragment 2 (0.83 kb) from chromosomal DNA of 
Bhe RSE247. Both fragments were combined by megaprime PCR with oligonucleotide 
primers prTR041 and prTR044 resulting in a fragment of 1.68 kb. The product was 
digested by BamHI and ligated into the corresponding site of pTR1000, yielding to pPG161. 
On the second step oligonucleotide primers prPG236 and prPG219 amplified fragment 1 
(1.07 kb with flanking BclI and BamHI sites) and prPG220 and prPG221 amplified fragment 
2 (1.04 kb with flanking BamHI, SalI and XhoI sites) from chromosomal DNA of Bhe 
RSE247. Both fragments were combined by megaprime PCR with oligonucleotide primers 
prPG236 and prPG221 resulting in a fragment of 2.09 kb. The product was digested by BclI 
and XhoI, and ligated into BamHI/SalI-digested pPG161, yielding to pPG611. 
On the last step oligonucleotide primers prPG212 and prPG213 amplified the intergenic 
region of Bhe bepC to bepD with tag encoding MYC epitope and flanking BamHI site as 
fragment 1. Oligonucleotide primers prPG214 and prPG215 amplified the beta-lactamase 
gene from pBR322 with flanking SacII and NotI sites as fragment 2. Oligonucleotide 
primers prPG216 and prPG217 amplified the BID domain and terminator downstream of 
bepD from RSE247 chromosomal DNA with flanking NotI and SalI sites as fragment 3. All 
tree fragments were combined by megaprime PCR with oligonucleotide primers prPG212 
and prPG217 resulting in a fragment of 1.96 kb. This fragment was digested with BamHI 
and SalI and ligated into previously BamHI/SalI-cut pPG611, yielding pPG612. 
The use of pPG612 for gene replacement in RSE247 resulted in the Bhe PGH75. 
Suicide vector pPE0012 for chromosomal integration for Bbi was constructed based on 
pPE0010, which was used for another approach as chromosomal insertion of “CP1-
Katushka-Tn” fragment into Bbi. pPE0010 originates from pPE002, a direct derivative of 
pSH003 were the direction of one of the two T7 promoter sequences at the two ends of 
the Transposon is modified. The oligonucleotide pair prPE427 and prPE428 amplifyed PCR 
fragment from pRS51, the product was digested with PacI/XbaI and was ligated into the 
corresponding site of pPE0010, yielding pPE0012. 
The use of pPE0012 for gene replacement in PEE0261 resulted in the Bbi-Tn-cre CMB0142. 
3 - Results and Discussion 
Page | 69  
 
Tyrosine to phenylalanine exchange mutant in BepEBhe 
To exchange the putatively phosphorylated tyrosines to phenylalanines in the N-terminus 
of BepE, we applied megaprime PCR to reamplify the sequence coding for BepE from 
pPG185. Briefly, using prPG190 and prPG191 binding on the plasmid pPG185 and two 
corresponding primers annealing to the site to be mutated, two fragments with a 
sequence overlap in the mutation site were amplified by PCR. In a second step, these two 
fragments were joined by megaprime PCR using prPG190 and prPG191, yielding a 
fragment of 2.1 kb. This fragment was then cut with NdeI and inserted into the previously 
NdeI-cut pPG180 vector. The Y37F; Y64F; Y91F; Y106F; Y129F (BepEBhe.Y->F) mutant was 
generated after sequential mutation rounds using pPG185 as a template on a first round.  
 
Western blot analysis of protein expression in Bartonella 
Western blot analysis of expressed protein levels in Bartonella was performed as 
described previously by Schulein et al., 2005 [21]. 
 
Infection of rats and mice  
Female Wistar rats were obtained at the age of 10 weeks from Harlan, RCC-Füllinsdorf. 
Rosa26 loxp-GFP Balb/c mice were bred in-house, at the animal facility of Biozentrum. All 
animal studies were approved by the authors' institutional review boards. 
The rats after two weeks of adaptation and the mice in the age between 6-12 weeks were 
infected with Btr and Bbi respectively. Bacterial strains were grown as described above, 
harvested in phosphate-buffered saline (PBS), and diluted to OD595 = 1. Rats were 
anesthetized with a 2–3% Isoflurane/O2 mixture and infected with 10 µl or 0.2 mL of the 
bacterial suspension in the dermis of the right ear or in the tail vein respectively. Mice 
were injected intradermally with 10 µl of bacterial suspension with the same 
concentrations mentioned above. Blood samples were taken at the tail vein and 
immediately mixed with PBS containing 3.8% sodium-citrate to avoid coagulation. After 
freezing to −70°C and subsequent thawing, undiluted and diluted blood samples were 
plated on Columbia agar plates containing 5% defibrinated sheep blood (CBA plates) at 
35°C and 5%. CFUs were counted after 7–10 days of growth. 
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Cell culture 
Human umbilical vein endothelial cells (HUVEC) were isolated as described before (Dehio 
et al., 1997) and cultured in EGM medium (http://www.promocell.com) in a humidified 
atmosphere at 37°C and 5% CO2. 
Bone marrow-derived DCs (BMDCs) were differentiated in vitro using standard protocol 
[61]. Briefly bone marrow cells were flushed from the tibias and femurs of Rosa26 loxp-
GFP Balb/c mouse with culture medium composed of DMEM medium (Invitrogen Life 
Technologies) supplemented with 10% FCS (Invitrogen Life Technologies). After one 
centrifugation, BM cells were resuspended in Tris-ammonium chloride for 2 min to lyse 
RBC. After one more centrifugation, BM cells were cultured for 8-10 days at 1 x 106 
cells/mL in culture medium supplemented with 200 ng/ml recombinant human Flt3L 
(produced by 40E1 hybridoma cells, kind gift from prof. A. Rolink, not published) in 75 cm2 
flasks (Corning life sciences). Cultures were incubated at 37°C in 5% CO2-humidified 
atmosphere.  
 
HUVEC transfection 
HUVECs were transfected using Amaxa nucleofection technology (Amaxa, 
http://www.amaxa.com) following the manufacturer’s guidelines for HUVEC transfection. 
After transfection, cells were seeded into gelatine-coated six-well plates. 
 
Lentiviral transformation of HUVECs 
Sub-confluent (3*106) HEK 293T cells in 10 cm cell-culture dishes were transfected with a 
total of 5 μg of plasmid DNA following the FuGENE transfection protocol (FuGENE 6 
Transfection Reagent, Roche). After 12 hs, the cell culture media was replaced and the 
cells were kept in culture for virus production in the supernatant for additional 24 
hs. 7*104 HUVECs/well was seeded in gelatin coated 6-well plate 24 hs before the viral 
infection. On day of infection the viral supernatant from transfected HEK 293T cells was 
filtered with 0.45 µm filter and transferred onto the monolayer of HUVECs, 2 mL of viral 
supernatant in presence of 0.5 µg/mL Polybrene (Sigma) was applied on each well. After 
the first harvesting of viral supernatant the HEK 293T cells were supplemented with a 
fresh medium. 24 hs later the HUVECs were re-infected repeating the same procedure 
with followed replacement of the medium in 24hs. 
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Infection of HUVECs  
HUVEC (passage 4-7) were plated on gelatin-coated glass slides in 24-well plates at 
5*104/ml using EGM or alternatively 3*103/well seeded in 96-well plate. The next day 
cells were washed twice with M199 with Earls salts (M199, Gibco, 
http://www.invitrogen.com) supplemented with 10% fetal calf serum (FCS, 
http://www.invitrogen.com) and infected with a multiplicity of infection (MOI) of 200 
bacteria per cell in M199/10% FCS/500 μM IPTG and incubated for 24, 36 and 48 hs or 
72hs for the time lapse microscopy. When necessary the infection was fixed with 3,7% 
paraformaldehyde. 
 
Immunofluorescent labelling 
Indirect immunofluorescent labeling was performed as described (Dehio et al., 1997)[31]. 
Standard 96-well plate assays were stained with TRITC-phalloidin (Sigma, 100 µg/ml stock 
solution, final concentration 1:400) and DAPI (Roche, 0.1 mg/ml) using a Tecan Eoware 
freedom pipetting robot. Glass slides for confocal microscopy were stained with Cy3- or 
Cy5-phalloidin (Sigma, 100 µg/ml stock solution, final concentration 1:100), DAPI and anti-
MYC antibodies (mouse anti-MYC, Invitrogen, Carlsbad, CA/USA) and/or VE-Cadherin 
(rabbit anti-VE-Cadherin, Bender MedSystems, Burlingame, CA/USA). Secondary 
antibodies for Immunofluorescence used in this study were Cy5-conjugated goat anti-
rabbit Ig antibodies (Dianova, Hamburg, Germany, 1:100). For HUVECs transfected with 
pRO1000, Cy5-phalloidin was used for staining of F-actin and DAPI for staining of nuclei. 
 
Image analysis and quantification of cell fragmentation 
Experiments performed in 96-well plates were subjected to automated microscopy, using 
MD ImageXpress Micro automated microscopes. In every well, 10 sites were imaged in 
two different wavelengths corresponding the applied cell staining. Images were visualized 
using MetaExpress software (MDC) and the number of cells per image was determined 
automatically by MetaExpress in-build analysis modules (CountNuclei). The thin 
elongations of the cells and cellular fragments without nucleus were defined and counted 
by eye. Using the automatically determined cell number and the manual cell elongation 
and cell fragment counts, the percentage of elongated cells and the fragment number per 
cells was calculated using Microsoft Office Excel. In every condition 20 fields of 
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magnification 20 within the well and triplicates of the wells were analyzed. The error bars 
were calculated as SD within the replicas. Statistical significance was determined using 
Student's t-test. *P<0.005, **P<0.001 were considered statistically significant. 
For confocal laser microscopy, the stained samples were analysed using an IQ iXON 
spinning disc system from Andor in combination with an Olympus IX2-UCB microscope. Z-
stacks with 20–30 focal planes with a spacing of 0.1–0.2 µm were recorded and xz -and 
yz-planes were reconstructed using Andor IQ software. Images were exported and 
finalized using Metamorph, ImageJ and Adobe photoshop. 
 
Time-lapse microscopy 
Time-lapse microscopy was carried out using an MD ImagXpress Micro automated 
microscope from Molecular devices (inside a controlled chamber held at 37°C and 5% CO2) 
and images recorded using a CoolSNAP ES digital CCD camera and processed using 
MetaXpress software (http://www.moleculardevices.com). Briefly, HUVECs were infected 
with Bhe strains in 96-well format as described above. After incubating for 8h, 2 to 4 
points in each well were chosen for time-lapse microscopy. The points were imaged for 
72hs with 10 min lapse between each imaging. Both, red and green,   fluorescence were 
detected at 20× magnification, and the corresponding videos were processed in 
MetaXpress and compiled into Quicktime (Apple, Cupertino, CA) movies.  
 
Infection and FACS analysis of BMDCs 
Day 9-10 BMDCs were harvested from the flask by vigorous pipetting followed by washing 
twice with room temperature PBS without Ca2+ or Mg2+ (Invitrogen Life Technologies). 
2*106 BMDCs were seeded in each well of 6-well plate. On the next day supernatant was 
replaced with the fresh M199 with Earls salts (M199, Gibco, http://www.invitrogen.com) 
supplemented with 10% fetal calf serum (FCS, http://www.invitrogen.com) and infected 
with a MOI of 50. On day 2 post infection (dpi) 20 μg/ml gentamicin was added for 2 hs 
and followed replacement with the fresh media. On 2 dpi and 3dpi infected BMDCs were 
scraped from the surface by lifter (Corning Life Science), re-suspended as single cell 
suspension and stained for surface markers. For staining following mAbs were used: anti-
B220 (RA3-6B2) PE, anti-CD11c (HL3) APC, purchased from BD Biosciences (San Jose, CA); 
anti-MHC class IIb PE antibodies were purified from the hybridoma supernatant and 
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labeled by standard methods (kind gift from prof. Antonius Rolink). For surface 
phenotyping, cells were incubated in FACS buffer (PBS, 1% FBS, and 0.1% azide) for 20 
min at 4°C with anti-CD11c APC and either anti-B220 PE or anti-MHCIIb PE. Cells were 
washed and resuspended in PBS containing 2% FCS and 0.1% sodium azide 
(FACSwash). Propidium iodide was used at 0.5 μg/ml. Flow cytometry was performed 
using a FACS Calibur (BD Biosciences) and data were analyzed using the FlowJo software. 
 
Beta-lactamase reporter assay 
3,5*103 BMDCs/well seeded in 96-well plate. On the next day the cells were infected with 
Bhe strains as described above with the MOI of 50, 100, 300. After 12, 24 and 48 hs post 
infection the infected cells were loaded with CCF2-AM (cephalosporin core linked 7-
hydroxycumarin) following the standard protocol (http://www.invitrogen.com) and 
translocation was determined by measuring the ratio of cleaved (460 nm) to uncleaved 
(530 nm) CCF2-AM. Specimens in a 96-well plate format were imaged with an MD 
ImagXpress and quantification was performed with CellProfiler.  
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Table 1: Bacterial strains and plasmids used in this study 
 
Strain or plasmid Genotype or relevant characteristics Reference  
 
Plasmids 
pRS40  vector for expression of (4) 
 NLS-Cre-MobA fusion proteins 
pBR322 broad host range resistance plasmid 
pPG100 E.coli-Bartonella shuttle vector,  (4) 
 encoding a short FLAG tag 
pTR1000 Basic mutagenesis vector to generate in-frame [21] 
 mutants in RSE247 and RSE149 
pHS003 suicide transposon vector [35] 
pPE002 suicide transposon vector,derivative of pSH003 this study 
pPE0010 Tn mutagenesis vector,derivative of pPE002 this study 
pPE0012 Tn mutagenesis vector,derivative of pPE0010 this study 
pPG110 E.coli-Bartonella shuttle vector,   this study 
 for tag-less expression  
pPG180 E.coli-Bartonella shuttle vector,  this study 
 encoding a short MYC tag 
pPG184 E.coli-Bartonella shuttle vector,  this study 
 encoding MYC -BepDBhe 
pPG163 derivative of pTR1000 to generate in-frame this study 
 mutants of RSE247 
pPG161 derivative of pTR1000 to generate pPG611 this study 
pPG611 derivative of pTR1000 to generate pPG612 this study 
pPG612 derivative of pTR1000 to generate chromosomal this study 
 insertion to RSE247 
pFS20 derivative of pTR1000 to generate in-frame this study 
 mutans of RSE149 
pPG104 encoding FLAG-BepDBhe [2] 
pPG105 encoding FLAG-Bep  Bhe [23] 
pPG106 encoding FLAG-BepFBhe [23] 
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Table 1 continued 
 
Strain or plasmid Genotype or relevant characteristics Reference  
 
pPG185 encoding MYC-BepEBhe this study 
pPG185.M118 encoding MYC-BepE_FFFFFBhe this study 
pPG172 encoding MYC-BID1/2Bhe this study 
pRO104 encoding MYC-BID2Bhe this study 
pRO105 encoding MYC-BepEBqu this study 
pRO107 encoding MYC-BepHBgr this study 
pFS31 encoding BepDBtr,  this study 
pFS32 encoding BepEBtr  this study 
pFS33 encoding BepDBtr,,BepEBtr this study 
pFS01 encoding FLAG-BepDBtr  this study 
pFS02 encoding FLAG-BepEBtr this study 
pPG213 encoding MYC-BepDBtr this study 
pPG214 encoding MYC-BepEBtr 
pCMV-FLAG2 eukaryotic expression vector, Eastman Kodak, 
 encoding a short FLAG tag New Haven  
pWAY21 plasmid for ectopic expression of Molecular Motion 
 N-terminal eGFP fusion proteins Montana lab 
pRO1000 eukaryotic expression, this study 
 encoding FLAG-GFP-BepE 
 
Lenti Viral plasmids 
 
pLenti-mCherryLifeact encoding mCherry LifeAct   O. Pertz, unpublished 
pMDL   packaging vector for plenty   O. Pertz, unpublished 
pREV   packaging vector for plenty   O. Pertz, unpublished  
pVSVG   packaging vector for plenty   O. Pertz, unpublished  
 
 
 
 
3 - Results and Discussion 
Page | 76  
 
Table 1 continued 
 
Strain or plasmid Genotype or relevant characteristics Reference  
 
E. coli strains 
 
NovaBlue endA1 hsdR17(r K12–m K12+) supE44 thi-1 recA1 Novagen, Madison 
 gyrA96 relA1 lac[F’ proA+B+ lacIqZΔM15::Tn10 (TcR)]  
β2150  F' lacZDM15 lacIq traD36 proA+B+ thrB1004 pro [31] 
 thi strA hsdS lacZΔM15 ΔdapA::erm (ErmR) pir 
 
Bartonella henselae strains 
 
RSE247 Spontaneous SmR strain of ATCC 49882T, [21] 
 serving as wild-type Bhe 
RSE242 ΔvirB4 mutant, derivative of RSE247 [22] 
TRB106 ∆bepB-G mutant, derivative of RSE247 [21]  
PGC80 ∆bepD mutant, derivative of RSE247 [60] 
PGD20 ∆bepE mutant, derivative of RSE247 [60] 
TRB222 ∆bepF mutant, derivative of RSE247 [60] 
PGE26 ∆bepDEF mutant, derivative of RSE247 this study 
PGD21 ∆bepE mutant, containing pPG185 this study 
ROB109 ∆bepE mutant, containing pPG172 this study 
ROB111 ∆bepE mutant containing pRO104  this study 
ROB113 ∆bepE mutant containing pRO105  this study 
ROB117 ∆bepE mutant containing pRO107  this study 
ROB119 ∆bepE mutant containing pPG214  this study 
ROB121 ∆bepE mutant containing pPG213 this study 
PGD67 ∆bepDEF mutant, containing pPG185 this study 
ROB141 ∆bepDEF mutant containing pPG172 this study 
ROB143 ∆bepDEF mutant containing pRO104  this study 
ROB145 ∆bepDEF mutant containing pRO105  this study 
ROB149 ∆bepDEF mutant containing pRO107  this study 
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Table 1 continued 
 
Strain or plasmid Genotype or relevant characteristics Reference  
 
ROB151 ∆bepDEF mutant containing pPG214  this study 
ROB153 ∆bepDEF mutant containing pPG213  this study 
PGH75 chromosomal integration of  this study 
 Bla-BIDBepDBhe, derivative of RSE247 
 
Bartonella tribocorum strains 
RSE149 Spontaneous SmR strain, [15] 
 serving as wild-type Btr 
FS150 ∆bepDE mutant, derivative of RSE149 this study 
FS179 ∆bepDE mutant, containing pFS32 this study 
FS180 ∆bepDE mutant, containing pFS33 this study 
ROA150 ∆bepDE mutant, containing pPG105  this study 
ROA158 ∆bepDE mutant, containing pPG185.M118  this study 
ROA168 ∆bepDE mutant, containing pPG172  this study 
 
Bartonella quintana strain 
RSE356 Spontaneous SmR strain, [25] 
 serving as wild-type Bqu 
 
Bartonella grahamii strain 
CHDE142 No 376, isolated from Microtus sp. [27] 
 serving as wild-type Bgr 
 
Bartonella Birtlesii strains 
PEE0261 IBS325T [28] 
 serving as wild-type Bbi 
CMB0142 Bbi-Tn-cre, derivative of PEE0261 this study 
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Table 2: Oligonucleotides used in this study 
 
Name Sequencea Restriction sites 
 
prTR15 ATAAGAATGCGGCCGCGATGAAAAGAAATCAACCACCCC NotI 
prTR16 CGGGATCCTTAGATGGCGAAAGCTATTGCC BamHI 
prTR041 CGGGATCCGCACACTCTGTGGAAAAACC BamHI 
prTR042 CGGGATCCTTAGCTGGCAATAGCAAGCG  BamHI 
prTR043 ATAAGAATGCGGCCGCGATGTTAGAGCATAATTATCTGTAT NotI 
prTR044 ATAAGAATGCGGCCGCGATGAAAAAAAAACAACCAGCCC NotI 
prTR051 CAACCATCCCCTCCGACTCCCACAAATCAAAAAGGA  
prTR055 CACAAAAAATGGTGCTGGC  
prTR056 GCTCTAGAGGCGTTACACAGGGAAGAG XbaI 
prFS09 CGGGATCCGCTTTCGTCGTTGGGCACA BamHI 
prFS10 ATCTGTTTTATGTTTATGCCACTTTAGCCTGTAAGA 
 GCCAGTG 
prFS11 CACTGGCTCTTACAGGCTAAAGTGGCATAAACATAA 
 AACAGAT 
prFS12 CGGGATCCTTTGAATTTCCTGCATTTTTTCTT BamHI 
prFS01 CGGGATCCGGAATTCCCATATGAAAAAACATCATCCACACCCA BamHI, NdeI 
prFS02 CGGGATCCGGAATTCCCATATGTTACATGGCATAAGCCATTCC BamHI, NdeI 
prFS17 CGGGATCCGGAATTCCATATGGTGAAAAAAAGTCACCCACAAC BamHI, NdeI 
prFS18 CGGGATCCGGAATTCCATATGTTACATGGCATAAGACATTCCT BamHI, NdeI 
prPG90 CGCGAGCTCTTTAAGAAGGAGATATACATATGGG SacI, NdeI 
 GATGCCTGGCAGTTTAT 
prPG91 CGCGAGCTCTAAATCAGAACGCAGAAGCG SacI 
prPG101 GGAATTCCATATGTTAGATGGCGAAAGCTATTGC NdeI 
prPG141 CGCGCTTATTAATGGAACAAAAACTTATTTCTGAA AseI, NdeI 
 GAAGATCTTCATATGAAAAAAAATCGACCATCCCCT 
 
aRestriction endonuclease cleavage sites are underlined 
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Table 2: continued 
 
Name Sequencea Restriction sites 
 
prPG142 CGCGCTTATTAATCATATGTTACATACCAAAGGCCA AseI, NdeI 
 TTCC 
prPG190 GCTCCGCCATCGCCGCT 
prPG191 GGATTTGAACGTTGCGAAGC 
prPG212 CGCGGATCCACACGTGAGATATCTATAATTCTCTCTCTG  BamHI  
prPG213 AGCCGCGGCAAGATCTTCTTCAGAAATAAGTTTTTGTTC SacII 
 CATGCATGCTTCCTTTCAAGC 
prPG214 CTTATTTCTGAAGAAGATCTTGCCGCGGCTCACCCAGAAA  SacII 
CGCTGGTG 
prPG215 TGCGGCCGCCCAATGCTTAATCAGTGAGGCAC NotI 
prPG216 GATTAAGCATTGGGCGGCCGCTGGAGTTGGCCC NotI 
AGGAAGG 
prPG217 ACGCGTCGACACATTTCATAACACTTCTTGGCGCAC  SalI 
prPG219 GGATCCCAAGCTTTCTCAATAGCAATATTTGTTTTTG BamHI 
 AAAGC 
prPG236 CCGAATTCTGATCAAGAAATAATTCCACCTCTTAGT  
 TACGTGG 
prPE247 CCGTTAATTAATATTCTGAAATGAGCTGTTGAC PacI 
prPE248 CCGTCTAGACAGAACGCAGAAGCGGTCTG XbaI 
prRO030 GGAATTCCATATGCATCCTGAAAGGGAGAGAC  NdeI 
prRO033 GGAATTCCATATGAAAAAAAACCAACCATCCTC  NdeI 
prRO034 GGAATTCCATATGTTAGCTGGCGAAAGCTATTGC  NdeI 
prRO037 GGAATTCCATATGAAAAAACATCATCCACACCC  NdeI 
prRO038 GGAATTCCATATGTTACATGGAATAAGCCATACC  NdeI 
 
aRestriction endonuclease cleavage sites are underlined 
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Figure Legends 
Figure 1: Invasion of red blood cells (RBCs) with Btr is delayed for 4 days in 
i.d. infection compared to i.v. route.  
Groups of rats (n = 5) were injected with phosphate-buffered saline (PBS) solution 
containing Btr wild type either intravenously (i.v.) in the tail vein of intradermally (i.d.) on 
the ear (200 μl and 10 μl respectively bacterial suspension, OD595=1). Blood samples were 
collected from the tail vein with 10% sodium-citrate supplementation at the time points 
indicated on the graphs. The blood cells were lysed by freezing the whole blood. 
Undiluted and serial dilutions of thawed blood in PBS ware plated on sheep blood 
supplemented columbia agar plates (CBA) for counting colony forming units (CFU) per mL 
of blood. Plotted graphs represent an average of bacterial number/mL of blood in animals 
groups from which bacteria were recovered at the given time points post-infection. The 
error bars represent standard deviation for the groups of animals. 
 
Figure 2: Rats infected with Btr ΔbepDE do not develop blood stage 
infection.  
Groups of rats (n= 5) were injected i.d. with PBS solution containing Btr wild-type or Btr 
ΔbepDE (10 μl bacterial suspension in PBS, OD595= 1). Blood samples were collected from 
the tail vein with 10% sodium-citrate supplementation at the time points indicated on the 
graphs. The blood was frozen to lyse red blood cells, undiluted and serial dilutions of 
thawed blood in PBS were plated on CBA for counting CFUs per mL of blood. Plotted 
graphs represent time course of single animals from which bacteria were recovered at a 
given time point post-infection. Each value corresponds to an average acquired from 
serial dilutions. One animal out of 5 (out of 13 in combined results from 3 independent 
experiments) infected with ΔbepDE detected in the blood with few days delay compared 
to wild-type infected rats. However, after reaching the blood stream the knockout strain 
was as successful as wild-type in colonization of blood showing high titers of bacteria. 
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Figure 3: Complementation of abacteremic phenotype of Btr ΔbepDE.  
Groups of rats (n = 3 for i.v., n= 5 for i.d.) were injected with PBS solution containing Btr 
corresponding strains depicted on the graph (200 μl and 10 μl of OD595= 1 for i.v. and i.d. 
respectively). Blood samples were collected from the tail vein with 10% sodium citrate 
supplementation at 16 days post infection (dpi). The blood cells were lysed by freezing 
the whole blood. Undiluted and serial dilutions of thawed blood in PBS ware plated on 
sheep blood supplemented CBA for counting CFU per mL of blood. Plotted graph 
represents data of single animals (circles) with an average (line) of the values from serial 
dilutions within the group of animals, (similar observation was obtained after 10 dpi). Btr 
ΔbepDE behaved as wild-type when directly delivered in the blood (i.v.) and reached the 
same high titers but was not detectable in the blood using the i.d. route of infection. The 
blood abacteremic phenotype of Btr ΔbepDE could be rescued by over expression of 
plasmid encoded BepDBtr and BepEBtr or BepEBtr alone in trans. BepEBhe could functionally 
replace BepEBtr and enabled Btr ΔbepDE to colonize the blood. 
 
Figure 4: Tyrosine containing motives of BepE are not essential for 
Bartonella to reach the blood.  
A. Groups of rats (n = 3 for control groups, n = 5 for complementation strains) were 
injected i.d. with PBS solution containing 10 μl of OD595= 1 of Btr corresponding strains 
depicted on the graph. Blood samples were collected from the tail vein with 10% citrate 
supplementation at the time points indicated on the graph. The blood was frozen to lyse 
red blood cells, undiluted and serial dilutions of thawed blood in PBS were plated on CBA 
for counting CFU/mL of blood. Plotted graph represents data of single animals with an 
average of serial dilutions, at 16 days post-infection. Both mutants of BepEBhe are 
complementing Btr ΔbepDE phenotype, showing no essential role of the tyrosine 
containing motives and the N-terminal part of BepEBhe in colonization of natural host. 
B. Protein levels of BepEBhe and BepEBhe mutant expressions by heterologous 
complementation in Btr ΔbepDE. α-BepEBhe western blot of bacterial total lysate (OD595= 
2) is presented. 
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Figure 5: Infection with Bhe ΔbepE or ΔbepDEF leads to the fragmentation 
of HUVECs. 
A. The monolayer of HUVECs was infected for 24 h, 36 h and 48 h with MOI=200 of Bhe 
wild-type, Bhe ΔbepE or Bhe ΔbepDEF mutants followed by fixation, immunocytochemical 
staining and confocal laser scanning microscopy. F-actin is represented in red and 
bacterial DNA and cell nucleus in blue (scale bar = 25 μm). Panel for Bhe ΔbepE and Bhe 
ΔbepDEF shows the cell elongation starting at 24 hpi, going from dramatic to extreme on 
36 and 48 hpi and forming fragments without nucleus. 
B. Cell fragmentation was quantified in semi-automated manner. HUVECs in 96-well 
format were infected with Bhe strains depicted on the graph. 20 fields per well were 
imaged by MD ImageXpress Micro automated microscopes. The number of cells per 
image was determined automatically by MetaExpress in-build analysis modules 
(CountNuclei). The thin elongations of the cells were defined and counted by eye. The 
percentage of elongated cells is shown on the figure. In every condition 20 fields of 
magnification 20 within the well and triplicates of the wells were analysed. The error bars 
were calculated as SD within the replicas. Statistical significance was determined using 
Student's t-test. *P<0.005, **P<0.001 were considered statistically significant 
 
Figure 6: Multiple fragmentation of Bhe ΔbepE infected HUVEC in time-
lapse 
Prior to infection, HUVECs of an early passage were infected with lentiviral vectors 
encoding mCherry LifeAct. F-actin fluorescent HUVECs in 96 well format were infected 
with MOI=200 of Bhe ΔbepE. At 8 hpi infected cells were exposed to MD ImageXpress 
Micro automated microscope for live cell imaging. Snapshots of gray scale images with 30 
min intervals are presented on the figure. The scale bar is for 25 μm. The errors are 
pointing to the regions of the cell where the fragmentation is taking place.  
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Figure 7: By providing BepEBhe in-trans on a plasmid, the ΔbepDEF-infected 
HUVECs do not undergo cell fragmentation.  
A. The monolayer of HUVECs was infected for 24 h, 36 h and 48 h with MOI=200 of single 
effector complemented Bhe ΔbepDEF-pbepDBhe, Bhe ΔbepDEF-pbepEBhe and Bhe 
ΔbepDEF-pbepFBhe strains followed by fixation, immunocytochemical staining and 
confocal laser scanning microscopy (scale bar = 25 μm). F-actin is represented in red and 
bacterial DNA and cell nucleus in blue. Panel for Bhe ΔbepDEF-pbepDBhe and Bhe 
ΔbepDEF-pbepFBhe shows that the cell elongation followed by fragmentation is not 
rescued; only BepEBhe was able to complement the cell fragmentation. 
B. Cell fragmentation was quantified in semi-automated manner as described above for 
Figure 5. 
 
Figure 8: The BID domains of BepEBhe are sufficient to inhibit the 
fragmentation of ECs. 
A. The monolayer of HUVECs was infected for 24h, 36h and 48h with MOI=200 of ΔbepE 
complemented with either both BID domains or the last C-terminal BID domain followed 
by fixation, immunocytochemical staining and confocal laser scanning microscopy (scale 
bar = 25 μm). F-actin is represented in red and bacterial DNA and cell nucleus in blue. 
Panels for Bhe ΔbepE-pBID1/2EBhe and Bhe ΔbepE-pBID2EBhe show that the cell elongation 
followed by fragmentation could not be rescued by the last BID domain of BepEBhe only, 
showing an intermediate phenotype. The two BIDs together were needed to inhibit the 
effect of the knock out strains. 
B. Alignment of two BID domains of BepEBhe shows 53.3% of pair wise identity. Geneious 
5.3.4. Software was used for the amino acid sequence alignment. 
C. Cell fragmentation was quantified in semi-automated manner as described for Figure 5.  
D. Protein levels of the two BIDs and the last C term BID of BepEBhe by over expression of 
pBID1/2E and pBID2E in Bhe ΔbepE and Bhe ΔbepDEF. The α-BepEBhe western blot was 
obtained from total lysate of (OD595= 2) wild-type Bhe and plasmid complemented strains.  
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Figure 9: BepEBhe homologs are able to inhibit fragmentation of HUVECs 
caused by Bhe ΔbepDEF.  
A. HUVECs were infected for 24 h,36 h and 48 h with MOI=200 of Bhe mutant strain 
complemented with the indicated Beps followed by fixation, immunocytochemical 
staining and confocal laser scanning microscopy. F-actin is represented in red and 
bacterial DNA and cell nucleus in blue (scale bar = 25 μm). Compared to BepEBtr, BepEBqu 
and BepHBgr, BepBtr revealed the lowest potency to inhibite the fragmentation. The time 
point 36 hpi is presented on the figure.  
B. Cell fragmentation was quantified in semi-automated manner as described for Figure 5. 
C. Protein levels of the BepEBhe homologs, BepEBqu, BepEBtr, BepDBtr and BepHBgr by over 
expression in Bhe ΔbepE and Bhe ΔbepDEF. The α-FLAG (M2) and α-Myc western blots 
were obtained from total lysate of (OD595= 2) Bhe wild-type and plasmid complemented 
strains.  
 
Figure 10: Ectopic expression of GFP-BepEBhe in HUVECs 
HUVECs of an early passage were electroporated according to the Amaxa nucleofection 
protocol with the plasmid encoding for CMV promoter driven GFP-BepEBhe. 24 hours post 
transfection (hpt) GFP-BepEBhe expressing cells were quantified by flow cytometery (A) 
and analysed by scanning confocal microscopy (B). Around 50 % of HUVECs expressed 
GFP-BepEBhe and BepEBhe localized to the plasma membrane. 
 
Figure 11: Ectopic expression of BepEBhe in HUVECs preserves the cells from 
fragmentation 
HUVECs of an early passage were transfected with the plasmid encoding CMV-promoter 
driven GFP or GFP-BepEBhe using the Amaxa nuceofection kit. After 24 hpt cells were 
infected with Bhe wild-type and Bhe ΔbepE. The infection was stopped at several time 
points as depicted on the figure followed by fixation, immunocytochemical staining and 
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confocal laser scanning microscopy (scale bar = 25 μm). F-actin is represented in red, 
bacterial DNA and cell nucleus in blue, GFP and GFP-BepEBhe in green.  
 
Figure 12: Effector translocation in Bbi infected BMDCs. 
BMDCs, cultured in vitro from Rosa26-loxP-egfp Balb/c transgenic mouse bone marrow in 
presence of Flt3L for 10 days, were infected with MOI=50 of either Bbi wild-type or Bbi-
Tn-cre strain (expressing a NLS-cre-BID fusion) for two days. 
A. GFP expression in infected cell culture was detected using a Leica DM-IRBE inverted 
fluorescence microscope. 
B. GFP-expressing cells from the live population on day 2 post infection of MBDC culture 
as analysed by flow cytometry. Upper panel of dot plots corresponds to the results 
obtained from wild-type Bbi infection of BMDCs. The lower panel shows the results for 
Bbi-Tn-cre infection.  
C. Quantification of GFP-expressing cells from the live population on day 2 and day 3 post 
infection of MBDC culture analysed by flow cytometry. The data are normalized, GFP+ 
cells quantified either in CD11c+ or CD11c- cell-population. Results from 2 independent 
experiments with duplicates are shown. 
 
Figure 13: Bbi iffected cells are CD11c+ dendritic cells.  
BMDCs from Rosa26 loxp-GFP Balb/c mice were infected with MOI=50 of either with Bbi 
wild type or Bbi-Tn-cre, after 3 days post infection infected cell culture was stained for 
CD11c and analysed by flow cytometry. 
A. Distribution of GFP and CD11c expressing cells in the whole population of BMDCs. UR 
(Upper Right) dot plot is an unstained wild-type infected control sample, LL (Lower Left) – 
stained for CD11c wild-type Bbi infected and LR (lower Right) – CD11c stained Bbi-Tn-cre 
infected . Results of one representative experiment out of 2 are shown. 
B. Quantification of GFP-expressing CD11c+ and CD11c- cells in BMDCs population. Error 
bars denote SD within replicas and different experiments. Results of 2 different 
experiments with duplicates are quantified. 
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Figure 14: Bbi infects pDCs and cDCs in vitro.  
BMDCs from Rosa26 loxp-GFP Balb/c mice were infected with MOI=50 of either Bbi wild 
type or Bbi-Tn-cre, after 3 days post infection infected cell culture was stained for CD11c 
in combination with either α-MHCIIb or α-B220 antibodies. The stained and unstained 
samples were analysed by flow cytometry.  
A. Distribution of GFP/MHCIIb and GFP/B220 expressing cells in the CD11c+ cell 
population of BMDCs is shown in the middle panel of dot plots. Results of one 
representative experiment out of 2 are shown.  
B. Quantification of MHCIIb/GFP-expressing infected DCs. The data are normalized to 
CD11c+MHCIIb+ and CD11c+MHCIIb- population.  
C. Quantification of GFP-expressing infected pDCs and cDCs. The data are normalized to 
CD11c+B220+ and CD11c+B220- population.  
Error bars denote standard deviation within replicas and different experiments. Results 
of 2 different experiments with duplicates are quantified. 
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Supplementary Figure Legends 
 
Suppl. Figure 1: BepEBhe localizes to the membrane of HELA cells and to the 
membrane and cell-cell contacts of infected HUVECs.  
A. Full-length MYC tagged BepEBhe (MYC-BepEBhe) and the two MYC tagged C-terminal BID 
domains (MYC-BID1/2EBhe). The (+++) indicates the positively charged tail sequence C-
terminally to the BID, required for the VirB/VirD4-dependent translocation. 
B. The two C-terminal BID domains of BepEBhe are sufficient to achieve localization to the 
plasma mambrane. HELA cells were infected for 48 h with MOI= 150, fixed, permeabilized, 
and stained for f-actin (red), MYC-tag (green), and total bacteria (blue). 1) uninfected cells, 
2) empty vector control, 3) MYC-BepEBhe, 4) MYC-BID1/2EBhe. The scale bar represents 20 
µm.  
C. Myc tagged BepEBhe localization to cell-cell contacts, co-localization with VE-cadherin. 
HUVECs were infected for 48 h with MOI= 150, fixed, permeabilized, and stained for VE-
Cadherin (red), MYC-tag (green), and f-actin (blue). 1) uninfected cells, 2) empty vector 
control, 3) MYC-BepEBhe, 4) MYC- BID1/2EBhe. The scale bar represents 20 µm. 
 
Suppl. Figure 2: The amino acid sequence similarity of BepEBhe homologs 
from different species of Bartonellae  
The BepE homologs from Bartonella species depicted on the figure (BepEBhe, BepDBtr, 
BepEBtr, BepEBqu and  BepHBgr) were aligned with the software Geneious Pro 5.3.4 . The 
amino acid sequence alignment with pair wise % identity is displayed here. The tyrosine-
containin N-termini and BID domains were aligned independently.  
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Suppl. Figure 3: PCR screen of the outcome clones from rats infected with 
Btr. 
The primer sets, prFS13/14 and prFS15/16, were used to amplify either BepDBtr or BepE 
Btr respectively from boiled colonies of the strains depicted on the graph. Neither BepDBtr 
nor BepEBtr PCR signal was detected from the clone recovered from the one rat infected 
with Btr ΔbepDE (rat # 606) that developed bacteremia starting at 16 dpi. 
 
Suppl. Figure 4: Complementation of the blood abacteremic phenotype of 
Btr ΔbepDE.  
Groups of rats (n = 3 for i.v., n = 5 for i.d.) were injected with PBS solution containing Btr 
corresponding strains 200 μl and 10 μl of OD595= 1 for i.v. and i.d. respectively. Blood 
samples were collected from the tail vein with 10% sodium citrate supplementation at 
day 10 p.i. The blood was frozen to lyse red blood cells, undiluted an serial dilutions of 
thawed blood in PBS were plated on defibrinated sheep blood supplemented CBA plates 
for counting CFU per mL of blood. Plotted graph represent data of single animals (circles) 
with an average (line) of the values from serial dilutions within the group of animals, 
(similar observation was obtained after day 16 post-infection). Btr ΔbepDE behaves as 
wild-type when directly delivered in the blood (i.v.), reaches the same high titers but is 
not detectable in the blood with i.d. route of infection. The blood abacteremic phenotype 
of Btr ΔbepDE can be rescued by over expression of plasmid encoded BepDBtr and BepEBtr 
or BepEBtr alone in trans. BepEBhe can functionally replace BepEBtr and enable Btr ΔbepDE 
to colonize the blood.  
 
Suppl. Figure 5: Maintenance of the plasmid in the blood of infected rats.  
Groups of rats (n = 5) were intradermally injected with PBS solution containing Btr 
corresponding strains, 10 μl of OD595= 1. Blood samples were collected from the tail vein 
with 10% citrate supplementation at the time points indicated on the graph. The blood 
was frozen to lyse red blood cells, undiluted an serial dilutions of thawed blood in PBS 
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were plated on plain CBA or CBA containing the resistance marker for the corresponding 
plasmid used for effector complementation in Btr ΔbepDE. The bar graph above shows 
the percentage of plasmid containing Bartonella within the pool of Btr recovered from 
the animal blood. The data are represented as average of the group of animals and serial 
dilutions of blood in PBS. Bartonella tend to lose plasmid during the infection, suggesting 
that there is no selection pressure to maintain it at the stage of blood infection. 
 
Suppl. Figure 6: Tyrosine containing motives of BepEBhe are not essential for 
Bartonella to reach the blood. 
Groups of rats (n = 3 for control groups, n= 5 for complementation strains) were i.d. 
injected with PBS solution containing Btr corresponding strains, 10 μl of OD595= 1. Blood 
samples were collected from the tail vein with 10% sodium citrate supplementation at the 
time points indicated on the graph. The blood was frozen to lyse red blood cells, 
undiluted and serial dilutions of thawed blood in PBS were plated on CBA for counting 
CFU per mL of blood. Plotted graph represents data of single animals (circles) with an 
average of serial dilutions within the group of animals (lines) at 10 days post-infection 
(similar observation was obtained after 16 dpi). Both mutants of BepEBhe are 
complementing Btr ΔbepDE phenotype, showing no essential role of tyrosine containing 
motives and BepEBhe N-terminal part in colonization of natural host. 
 
Suppl. Figure 7: The Bhe strains have the similar growth rates in infected 
cell culture.  
The monolayer of HUVECs was infected for 24 h, 48 h with MOI=200 of different strains of 
Bhe depicted on the graph above. The infected cell culture was lysed with 0.5% Saponin in 
PBS. The lysate and serial dilutions in PBS were plated on CBA plates to enumerate the 
CFUs per well. Plotted graphs represent an average of serial dilutions and duplicates per 
time point. Error bars denote SD within serial dilutions. Results of one representative 
experiment out of 3 are shown. 
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No major difference was detected in growth of different Bhe strains used for in vitro 
infections that could potentially explain the different toxicity of strains to the infected 
cells and earlier fragmentation process as compared to wild-type 
 
Suppl. Figure 8: Ectopic expression of BepEBhe in HUVECs preserves the cells 
from fragmentation 
HUVECs on an early passage were transfected with the plasmid encoding CMV-promoter 
driven GFP or GFP-BepEBhe using Amaxa nuceofection kit. After 24 h post transfection 
cells were infected with Bhe wild-type and ΔbepDEF. The infection was stopped at several 
time points depicted on the figure above followed by fixation, immunocytochemical 
staining and confocal laser scanning microscopy. F-actin is represented in red, bacterial 
DNA and cell nucleus in blue, GFP and GFP-BepEBhe in green. T4SS independent delivery of 
BepEBhe in HUVECs proves that interference of BepEBhe with other Beps and inhibition of 
fragnemtaion is a specific function and not the out competition in translocation when 
over expressed by plasmid in Bartonella. 
 
Suppl. Figure 9: Time course of bacteremia in Bbi infected Balb/c mice.  
The group of (n=7) Balb/c mice was intradermally injected with 10 μl of PBS containing 
Bbi wild-type bacteria (OD595=1). Blood samples were collected from the tail vein with 10% 
citrate supplementation at the time points indicated on the graphs. The blood was frozen 
to lyse red blood cells and undiluted an serial dilutions of thawed blood in PBS were 
plated on sheep blood supplemented CBA for counting CFU per mL of blood. Plotted 
graphs represent single animals from which bacteria were recovered at a given time point 
post-infection. 
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Suppl. Figure 10: Translocation of Bla-BID fusion by Bhe into infected bone 
marrow derived dendritic cells (BMDCs) from C57/BL6/J mice. 
BMDCs, cultured in vitro from C57/BL6/J mouse bone marrow in the presence of Flt3L for 
10 days, were infected with either Bhe wild-type or Bhe strain expressing Bla-BID fusion 
with the different MOIs described on the graph. Infected cells were loaded with CCF2-AM 
(cephalosporin core linked 7-hydroxycumarin) and translocation was determined by 
measuring the ratio of cleaved (460 nm) to uncleaved (530 nm) CCF2-AM. The plotted 
graph shows the percentage of cells that got translocation of Bla-BID fusion at given time 
points of the infection. Specimens in a 96-well plate format were imaged with an MD 
ImagXpress and quantification was performed with CellProfiler. The results shown 
represent the average of triplicate wells. Error bars denote standard deviation within the 
triplicates. 
 
Suppl. Figure 11: Comparison of the virB T4SS loci of B. birtlesii, B. henselae 
and B. tribocorum 
Sequence similarity is shown for genes having more than 30% amino acid identities over a 
sequence stretch of more than 250 amino acids. VirB T4SS genes are shown in yellow and 
VirB T4SS effector genes in green. 
Suppl. Movie 1: Random cell migration of uninfected and wild-type Bhe-
infected HUVECs. HUVECs express LifeAct and wild-type Bhe expresses GFP. The 
acquisition started at 8 hpi. Cells were imaged for 72hs with. The movie with 30 min time-
lapse between images is presented. 
Suppl. Movie 2: Cell fragmentation induced by Bhe ΔbepE. HUVECs expressing 
LifeAct are infected either wth Bhe ΔbepE (left side) or with Bhe ΔbepE-pbepE (right side). 
The acquisition started at 8 hpi. Cells were imaged for 72hs with. The movie with 30 min 
time-lapse between images is presented. 
Suppl. Movie 3: Multiple cell fragmentation induced by Bhe ΔbepDEF. 
HUVECs expressing LifeAct are infected either wth Bhe ΔbepDEF (left side) or with Bhe 
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ΔbepDEF-pbepE (right side). The acquisition started at 8 hpi. Cells were imaged for 72hs 
with. The movie with 30 min time-lapse between images is presented. 
Suppl. Movie 4: Cell fragmentation induced by Bhe ΔbepE. HUVECs expressing 
LifeAct (uninfected, upper left), HUVECs expressing LifeAct infected wth wild-type Bhe 
(upper right), with Bhe ΔbepE (left below) and ΔbepE-pbepE (right below). The acquisition 
started at 8 hpi. Cells were imaged for 72hs with. The movie with 30 min time-lapse 
between images is presented. 
Suppl. Movie 5: Cell fragmentation is T4SS-dependent. Phase contrast movies 
of HUVECs infected wth wild-type Bhe (upper left), HUVECs infected with Bhe ΔvirB4 
(upper right), with Bhe ΔbepE (left below) and uninfected HUVEC (right below). The 
acquisition started at 8 hpi. Cells were imaged for 72hs with. The movie with 15 min time-
lapse between images is presented. 
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Additional work (results unrelated to the manuscript) 
In this part I will describe my work unrelated to the manuscript (in preparation), mainly 
the work that has been carried out to characterize transgenic mouse line C57BL/6-
TgN(BepE-pPG2001)2001, the expression of BepEBhe under the promoter of CD11c
+. 
Additionally, I bring the results of in vitro secretion of IL-10 upon BMDC infection with Bhe 
and introduce the i.d. infection of C57/BL6/J mice with Bartonella taylorii. 
The plasmids used for generation of transgenic (Tg) mice were constructed by Dr. Patrick 
Guye during his last year of PhD study. Tg mice were generated by Daniela Klewe-
Nebenius, Transgenic Mice Core Facility (TMCF), Biozentrum. Tg mice analysis was 
performed by me, during my first year of PhD study, with the help of Dr. Lee Kim Swee at 
the laboratory of Prof. Antonius Rolink at DBM, University of Basel. 
 
1. Ectopic expression of BepE in CD11c+ cells of transgenic 
mice - C57BL/6-TgN(BepE-pPG2001)2001 
Bhe BepE is injected into infected eukaryotic cells as diverse as primary endothelial or 
dendritic cells (DCs). Upon injection into these cells, it localizes to the plasma membrane 
and to cell-cell contacts (P. Guye, Thesis work, 2006). BepE is tyrosine – phosphorylated 
by host cell kinases on its ITIMs, ITSMs and a Csk binding-like site. Upon phosphorylation 
these motifs interact with SHP1/2, Grb2/7 and Csk (within ITIM/ITSM and Csk-like binding 
motives respectively) [1]. The data accumulated so far, the localization and the cellular 
interaction partners, suggests that BepE mimics inhibitory immune receptors. The ability 
to control the activation of various immune cells by such mimicry might be one of the key 
factors in the success of Bartonella to cause long-term persistent infections. To assess the 
impact of this putative immunomodulatory protein on the immune response Tg mice, 
C57BL/6-TgN(BepE-pPG2001)2001, expressing BepE ectopically in DCs were generated. 
Tg mice were produced by microinjection of transgene DNA into fertilized murine oocytes. 
Transgene DNA was obtained from the plasmid construct - pPG2001, which encoded bepE 
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from Bhe under the control of CD11c promoter (Figure 1.A). Tg mice were bred 
heterozygously and the offspring was genotyped by PCR for the presence of trans gene 
with the primer pair prPG256/257(Figure 1.B). The expression of BepE in Tg mice was 
analyzed by flow cytometry in Flt3-differentiated BMDCs. Around 6% of BMDCs from Tg 
mice expressed BepE protein. (Figure 1.C). 
 
1.1. Maturation and Ag presentation properties of BMDCs from Tg mice  
DCs have a dual role to prime adaptive immune responses and to induce self-tolerance. 
Two important properties of DCs underlie their ability to exert these activities. First, the 
antigen sampling and migratory capacities of DCs effectively allow naive T cells to come 
into contact with peripheral antigens. Second, the ability of DCs to sense and translate 
environmental cues dictates, to a large extent, the fate of T cells that respond to such 
antigens. The mechanisms that are used by DCs to translate their environment for the 
benefit of lymphocytes are embodied in the concept of DC maturation. DCs can exist in 
two functional states, immature and mature. Only a mature DC has the ability to prime an 
immune response. High cell-surface levels of MHC molecules, CD40, CD80, CD83 and 
CD86 correlate with T-cell-priming ability, it is generally assumed that DCs that are 
mature by phenotypic criteria are also functionally mature, that is, immunogenic. 
However, phenotypically mature DCs do not always promote T-cell immunity and can, in 
fact, induce tolerance [24]. Thus DCs fine-tune immune responses by instructing T-cell 
differentiation and polarization. DCs transmit a distinct set of instructions to T cells that is 
based on their state of differentiation or maturation, and these instructions programme 
outcomes that range from humoral to cytolytic to suppressive (regulatory) T-cell 
responses [26]. 
Considering such a pivotal role of Ag presentation properties of DCs for the development 
of an effective immune response, we decided to investigate whether BepE expression has 
modulated these features in BMDCs of Tg mice. BMDCs were differentiated from the 
bone marrow of Tg and wild-type C57BL/6 mice in the presence of Flt3 ligand for 10 days. 
Differentiated BMDCs were stained for CD11c, B220, CD86, MHCII surface molecules; 
which allowed to distinguish cDCs and pDCs (Figure 2.A), and to characterize the 
activation status of these subpopulations (Figure 2.B). Mixed leukocyte reaction assay 
3 - Results and Descussion 
Page | 124  
 
was used to examine the allo-stimulation activity of BMDCs from wild-type Tg mice. 
Carboxyfluorescein diacetate, succinimidyl ester (CFSE) - labeled lymphocytes from the 
lymph nodes of Balb/c mouse were mixed with BMDCs obtained from C57BL/6 (wild-type 
and Tg) mice in different ratios: 5:1, 10:1, 50:1and 100:1. One sample contained plane 
lymphocytes as a negative control. 5 days after stimulation the leukocyte mixture was 
stained with anti-CD4 Abs and propidium iodide (PI). The stained samples were acquired 
by flow cytometry. The data were analyzed by Flowjo 7.2.4 software (Figure 2.C and 2.D). 
 
1.2. DCs in T cell development in the thymus 
DCs are involved in T cells development in the thymus. In more details, bone marrow-
derived MHCII+ thymic DCs at corticomedullary junction of thymus present circulatory Ags 
to the double positive (CD4+CD8+) thymocytes that have already undergone 
differentiation from double negative to double positive phenotype and positive selection 
in the cortex. Ag recognition and strong TCR signaling after contact with thymic DCs drives 
the double positive thymocytes to apoptosis. Thus DCs negatively select self Ag-
recognizing T cells and only about 1% of self tolerant thymocytes go on further 
maturation to single positive (CD4+ and CD8+) T cells [2,3]. 
We wanted to assess the impact of BepE expression on thymic DCs during T cell 
development. Thus, we analyzed the thymus from Tg mice for double negative and 
double positive thymocytes and single positive T cells.  
As compared to wilt-type, the thymus from Tg mice did not display any differences in the 
composition of all four cell types (Figure 3).Next to it we examined also peripheral 
lymphoid organs for the composition of T cell sub-populations. 
 
1.3. DCs in regulatory T cells (T regs) development 
T regs are characterized by expression of the transcription factor Foxp3 and they play key 
roles in the maintenance of lymphoid homeostasis in a number of immune circumstances. 
These cells maintain tolerance to self and control autoimmune deviation [4,5] prevent 
runaway responses to pathogens or allergens, help to maintain a balance with obligate 
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microbial flora [6], and facilitate tumors’ escape from immune monitoring. Two origins 
have been described for Foxp3+ cells. The first is the thymus, where Foxp3+ cells are 
generated roughly in sync with positive selection of CD4+ T cells. The second is the 
periphery, where a number of triggers induce the expression of Foxp3 in T cells [7]. In 
both of the cases DCs are the cells driving T cells to Foxp3+ cells as they serve as Ag-
presenting cells during the process. We assumed the putative inhibitory effect of BepE 
could influence on the proportion of T regs in thymus and peripheral lymphoid organs, 
such as spleen and lymph nodes. 
 
1.4. The impact of DCs on Natural Killer (NK) T cell development 
NK T cells have characteristics of both T and NK cells. They have TCRs like T cells and 
possess CD16, other typical receptors and killer activity like NK cells. NK T cells belong to a 
subset of T cells that has unique characteristics [8]. These cells are considered to be 
innate T lymphocytes that are restricted by MHC class I-like CD1d antigen-presenting 
molecules and recognize lipids and glycolipids as antigens [9]. The activated, NKT-cell 
population rapidly secretes large amounts of cytokines, especially interleukin IL-4 and 
IFN-γ. Because of their rapid response to the activation, NKT cells can regulate early 
immunological events in diverse situations, such as the control of autoimmune diseases in 
humans and mice, tumor rejection and especially they are involved in different bacterial, 
parasitic, fungal and viral infections [10,11]. Although the NK T cell development is poorly 
understood, it is believed that they develop in the thymus alongside mainstream T cells 
and that corticomedullar DCs are required for the negative selection during the 
differentiation of thymocytes into NK T cells [12]. Thus, considering the role of DCs in NK T 
cell development, we decided to analyze the spleen of Tg mice for NK T cells as well. 
 
1.5. Summary 
Based on our results we can summarize that no significant differences in different 
compartments of immune system of Tg and wild-type mouse were observed. BepE 
ectopic expression did not impair maturation and Ag presentation properties of DCs (in 
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vitro) and the development of T cells populations in thymus; or their composition in 
peripheral lymphoid organs. We speculate that the expression of BepE on protein level 
may not be high enough to result in obvious phenotypes, or some other compensatory 
mechanisms in the Tg mice avoid functional interference of BepE within the processes 
investigated above. 
Assuming that BepE, more specifically the BID domains of BepE, revealed a critical 
importance for the establishment of Bartonella infection in vivo and based on our 
hypothesis that DCs are the cells that deliver Bartonella from inoculation site, derma to 
the lymphatic-blood system, I plan to i.d. infect Tg mice (next to wild-type) with Bbi ΔBepE 
(I am currently constructing the mutant) and monitor the blood bacteremia of the 
infected animals. I am interested to investigate whether the ectopic expression of BepE in 
DCs may restore the bacteremia of Bbi ΔBepE infected reservoir host, based on the fact 
that BepEBtr and BepEBhe were able to complement the abacteremic phenotype of Btr 
ΔBepDE. 
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Figure Legends 
Figure 1: Genotyping and BepE expression in transgenic (Tg) mice 
A. Plasmid map of the construct, pPG2001, was used for the generation of Tg mice, where 
Bhe bepE-gene is under the control of CD11c promoter (by Geneious 5.3.4 software).  
B. prPG256/257 primer-pair were used to amplify the bepE trans gene on the genomic 
DNA extracted from the toe of Tg mouse. The genotyping PCR included amplification of 
NCAM gene as a control for genomic DNA. As a positive control for bepE gene pPG2001 
plasmid template was taken. Three out of 8 mice were positive for trans gene in the 
screen depicted on the figure. 
C. BMDCs were obtained from wild-type and Tg mice by Flt3 ligand treatment of bone 
marrow cells for 10 days. The cytoplasmic staining of differentiated BMDCs was 
performed with primary rabbit anti-BepE polyclonal antibodies and mouse anti-rabbit 
Alexa633 Abs were used as secondary Abs. The stained BMDC samples were acquired by 
flow cytometry and the cytoplasmic expression of BepE protein was analyzed by WinMDI 
2.8 software. 
 
Figure 2: Ag presentation and T cell stimulation by DCs 
BMDCs were obtained from wild-type (n=3) and Tg (n=3) mice by Flt3 ligand 
differentiation of bone marrow cells for 10 days. Differentiated BMDCs were stained for 
CD11c, B220, CD86, MHCII surface molecules; which allowed to distinguish cDCs and pDCs 
(A), and to characterize the activation status of these subpopulations (B). Samples were 
acquired by FACS and analyzed by Flowjo 7.2.4 software. The error bars denote standard 
deviation within the groups of animals. 
 C. Mixed leukocyte reaction assay was used to examine the allo-stimulation activity of 
BMDCs from wild-type (n=3) and Tg (n=3) mice. Carboxyfluorescein diacetate, 
succinimidyl ester (CFSE) - labeled lymphocytes from the lymph nodes of Balb/c mouse 
were mixed with BMDCs obtained from C57BL/6 (wild-type and Tg) mice in different 
ratios depicted on the graph. One sample contained plane lymphocytes as a negative 
control. 5 days after stimulation the leukocyte mixture was stained with anti-CD4 Abs and 
propidium iodide (PI). The stained samples were acquired by flow cytometry. The data 
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were analyzed by Flowjo 7.2.4 software. The cells were gated on CD4+population within 
live (PI negative) region and successive generations of proliferated T cells were observed 
by decresing intensity of CFSE . 
D. Quantification of T cell proliferation is presented on bar graph. The error bars stand for 
the standard deviation within the groups of animals analyzed. 
 
Figure 3: BepE expression in DCs does not impair CD4 and DC8 
development 
Single sell suspensions were obtained by homogenization of thymus, spleen and lymph 
nodes from wild-type (n=3) and Tg (n=3) mice. Cell suspension was double-stained for 
CD4 and CD8 with anti-CD4 FITC and anti-CD8 PE respectively. The data were acquired by 
flow cytometry and analyzed by WinMDI2.8 software. 
A. T cell development in thymus. A Representative dot plots for T cell distribution and 
quantification graphs are presented. The error bars denote standard deviation within the 
groups of animals. 
B. CD4 and CD8 T cell composition in spleen. A Representative dot plots for T cell 
distribution and quantification graphs are presented. The error bars denote standard 
deviation within the groups of animals. 
C. CD4 and CD8 T cell proportion in lymph nodes. A Representative dot plots for T cell 
distribution and quantification graphs are presented. The error bars denote standard 
deviation within the groups of animals. 
 
Figure 4: Regulatory T (T regs) cell-distribution in the organs is not impaired 
in Tg mice 
Single cell suspensions were obtained by homogenization of thymus, spleen and lymph 
nodes from wild-type (n=3) and Tg (n=3) mice. Cell suspension was double-stained for 
surface CD25 and intracellular Foxp3 with anti-CD25 and anti-Foxp3 respectively. The 
data were acquired by flow cytometry and analyzed by WinMDI 2.8 software. 
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A. T regs in the thymus. A Representative dot plots for T cell distribution and 
quantification graphs are presented. The error bars denote standard deviation within the 
groups of animals. 
B. T regs in the spleen. A Representative dot plots for T cell distribution and quantification 
graphs are presented. The error bars denote standard deviation within the groups of 
animals. 
C. T regs in lymph nodes. A Representative dot plots for T cell distribution and 
quantification graphs are presented. The error bars denote standard deviation within the 
groups of animals. 
 
Figure 5: The numbers NK T cells are not impaired in Tg mice 
Single sell suspensions were obtained by homogenization of thymus, spleen and lymph 
nodes from wild-type (n=3) and Tg (n=3) mice. Cell suspension was double stained for 
CD4 and CD8 with anti-CD4 FITC and anti-CD8 PE respectively. The data were acquired by 
flow cytometry and analyzed by WinMDI2.8 software. 
A. T cell development in thymus. Representative dot plots for T cell distribution and 
quantification graphs are presented. The error bars denote standard deviation within the 
group of animals. 
B. CD4 and CD8 T cells composition in spleen. Representative dot plots for T cell 
distribution and quantification graphs are presented. The error bars denote standard 
deviation within the group of animals. 
C. CD4 and CD8 T cells proportion in lymph nodes. Representative dot plots for T cell 
distribution and quantification graphs are presented. The error bars denote standard 
deviation within the group of animals. 
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2. Tolerance to Bartonella during long-term persistent 
infection  
The immune response has evolved to protect the host from a wide range of potentially 
pathogenic microorganisms, but parallel mechanisms to control over-exuberant immune 
responses and prevent reactivity to self are required to limit host damage. Interleukin-10 
(IL-10) is an anti-inflammatory cytokine with a crucial role in preventing inflammatory and 
autoimmune pathologies. IL-10 supports the differentiation of tolerogenic and anergic T 
cells by directly inhibiting the phosphorylation of CD28 and subsequent downstream 
signalling and efficiently inhibits the proliferation and cytokine production of those cells. 
Interleukin-10 is also recognized as stimulating the production of T cells with regulatory 
function that can suppress effector T-cell proliferation [27-30]. A number of cells of the 
innate and adaptive immune response produce IL-10, including DC and macrophages, Th1, 
Th2, Th17 and T regs [13]. 
Many chronic pathogens subvert host immunity by upregulating the expression of anti-
inflammatory cytokines, such as IL-10. Some viruses capable of establishing chronic 
infections produce viral homologues to IL-10. Although, no bacteria-encoded IL-10 
homologues have been described, bacteria can induce the secretion of endogenous IL-10 
and/or TGF-β from innate immune cells that respond to the infection [14]. DCs exposed to 
filamentous hemagglutinin (FHA) from Bordetella pertussis secrete IL-10 and inhibit LPS-
induced inflammatory cytokine production. Furthermore, these IL-10-secreting DCs 
induce the clonal expansion of T reg1 cells that are capable of suppressing the Bordetella-
specific Th1 immune response [15,16]. Chlamydia trachomatis induces the expression of 
IL-10 indirectly, by increasing prostaglandin E2 (PGE2) secretion levels. By this mechanism it 
encourages T reg function to interfere with the delivery of anti-chlamydial Th1 responses 
and minimize destructive inflammation of the infected genital tract tissue [27]. 
Bqu infection of homeless people (human is the only host known for Bqu) known as 
trench fever with recurrent fever, headaches and leg pain, is usually resolved within the 
month but 5-10% of the cases develop chronic bacteremia for longer times. Bqu 
bacteremia exhibited high IL-10 production and an attenuated inflammatory response, 
which may favor bacterial persistence [17]. The dependence of bacterial persistence on 
the elevated levels of IL-10 was confirmed experimentally by infecting IL-10-/- mice with 
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Bbi, where infected animals did not develop bacteremia [18]. Even more, IL-10 secretion 
and interference with the Th1 response against Bhe was observed in mouse, an incidental 
host infection model for Bhe [19]. 
In this regard, I was interested to investigate whether IL-10 production is connected to 
Bartonella effector proteins, especially to BepE as it shows a molecular mimicry to 
immune inhibitory receptors and bares putative ITIM/ITSM and Csk-like binding domain 
on the N term [1]. Potentially this molecule could modulate the immune response against 
Bartonella by inducing anti-inflammatory cytokine production and by this bacteria could 
favor in the establishment of long term infection. First, I decided to infect BMDCs, BMDCs 
and T lymphocytes as a co-culture with the ratio 1:5 and T lymphocytes from Balb/c 
mouse with wild-type and different mutant strains of Bhe at MOI of 50. After 24 hpi I 
measured the secretion of IL-10 in the supernatant of infected cells by indirect ELISA. As a 
result, I did not observe any clear dependence of IL-10 secretion on BepE. The IL-10 
secretion was BMDC specific and infections with the mutant Bhe showed high 
perturbations within independent experiments (Figure 6 and 7). In both conditions of 
BMDC infection, BMDCs alone or co-cultured with T cells, IL-10 was detected in the 
supernatant. However, infected T cells did not produce any IL-10. It is noteworthy to 
mention that I did not have a careful look whether effector translocation takes place in T 
cells. 
Next, I infected BMDCs from Myd88-/- mouse with the same pattern of Bhe strains, in 
order to confirm that IL-10 production is induced rather by TLRs signaling after Bartonella 
recognition than by BepE translocation via T4SS. Myd88 is a TIR domain-containing 
adaptor and associates with the cytoplasmic TIR domain of TLRs [20], thus it is in a very 
beginning of TLR signaling and if BepE has a potential to mimic even the TLR signaling, the 
IL-10 production would be observed. In addition, it is known that Bartonella has a 
modified LPS and it is not recognized by TLR4 [21,22], the only TLR receptor within the 
TLR-family, that has a Myd88-independent pathway next to Myd88-dependent signaling 
[23]. As a result, infected Myd88 BMDCs did not produce IL-10 (Figure 7), indicating that 
indeed, IL-10 production during Bartonella infection is TLR mediated and we speculate it 
is rather via TLR2 recognition of Bartonella lipopeptides, in line with the fact that heat 
killed Bqu is activating TLR2 signaling [21]. 
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Figure 1: IL-10 is secreted by infected BMDCs but not by infected T cells 
alone 
BMDCs (A), BMDC-T cell co-culture (the ratio 1 to 5 respectively) (B) and T cells (C) 
cultured in vitro from wild-type Balb/c mouse were infected (MOI=50) with either wild-
type Bhe or the mutant strains depicted on the graph. After 24 hpi the secreted IL-10 was 
detected in the supernatant of infected cell culture by indirect ELISA. BMDCs were 
cultured from the bone marrow in the presence of Flt3L for 10 days; the T cells were 
obtained from the lymph nodes. The bar graph shows the amount of secreted IL-10 per 
mL of supernatant from infected cell culture. The error bars denote standard deviation 
within triplicates. 
 
3 - Results and Descussion 
Page | 138  
 
 
Figure 2: IL-10 secretion by Bhe infected BMDCs is mediated via TLR 
receptors and is not Bep dependent 
BMDCs, cultured in vitro from Balb/c wild-type (A) or Balb/c Myd88-/- mouse bone 
marrow in the presence of Flt3L for 10 days, were infected (MOI=50) with either wild-type 
Bhe or mutant strains depicted on the graph. After 24 hpi the secreted IL-10 was detected 
in the supernatant of infected BMDC culture by indirect ELISA. The bar graph shows the 
amount of secreted IL-10 per mL of supernatant from infected cell culture. The similar 
results were observed from the later time points of BMDC infection with wild-type Bhe 
and the Bhe mutants. The error bars denote standard deviation within triplicates. 
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3. Infection of C57/BL6/J mice with Bartonella taylorii 
During the establishment of a mouse infection model for Bartonella, one of the 
candidates, with consideration of natural host specificity, was Bartonella taylorii (Bta). 
We wanted to characterize i.d. infection in C57/BL6/J mice, comparing Bta infection in 
two routs, i.d. versus i.v. and the followind bacteremia in blood from the tail vein. The 
animals with the i.d. injection of C57/BL6/J (Bta) underwent unusual signs that were not 
observed in any previous cases of Bartonella in vivo infections. Most of the i.v. infected 
mice had damaged tails with necrotic areas few days after infection (4 dpi). Starting from 
day 10 i.d. infected mice developed necrotic tissues on the ear, but not only at the site of 
infection. These observations are not Bartonella strain specific; the similar observations 
were seen in a parallel experiment with Btr infection of C57/BL6/J mice (data not shown). 
I assume this is rather mouse line specific phenomenon [25]. C57/BL6/J mice with 
stronger TH1 response and strong cytotoxic effect against Bartonella containing cells 
developed tissue necrosis. The phenomenon described here has not been investigated 
further. 
Although the bacteremia in C57/BL6/J mice reaches high titters, more than 107 bacteria 
per mL of blood, the system is not convenient to study long term infection of Bartonella 
because the animals with the necrotic lesions have to be sacrificed. 
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Figure : The time course of bacteremia in Bta infected C57/BL6/J mice  
The group of (n=3) C57/BL6/J mice were either i.v. or i.d. injected with PBS containing 
wild-type Bta bacteria (200μl and 10 μl of OD595=1 respectively). Blood samples were 
collected from the tail vein with 10% citrate supplementation at the time points indicated 
on the graphs. The blood was frozen to lyze red blood cells and undiluted and serial 
dilutions of thawed blood in PBS was plated on sheep blood supplemented CBA for 
counting colony forming units (CFU) per mL of blood. Plotted graphs represent a single 
animal from which bacteria were recovered at a given time point post-infection. Mice 
#254, 255, 257, 258 were sacrificed because of necrotic lesions on the tail and the ear.  
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4. Conclusions 
To summarize, my PhD thesis aimed investigation of the role of BepE in reservoir host 
infection. The in vitro analysis served to understand the cellular bases of the in vivo findings. 
Here, I will draw the conclusions on the main findings of my work. 
 
The establishment of rat intra-dermal infection model 
In order to closely mimic the reservoir host infection by BartonelIa I have established the rat 
intra-dermal (i.d.) infection model, inoculation of B. tribocorum in the ear dermis of the 
animal. This route of infection reflects the natural way of Bartonella transmission by 
arthropods when the bacteria are inoculated in the skin of a mammal via the feces of a 
vector after animal scratches [1]. The i.d. infected animals develop blood stage infection, 
which starts around 7-8 days post infection and lasts for 10 weeks. It is a long-term 
bacteremic infection without obvious clinical manifestations, a hallmark of the reservoir 
host infection by Batonellae. The time delay that Btr is taking to appear in blood 
corresponds to the way that bacteria need to pass from the derma to the lymphatic-blood 
system and to the possible interaction with the innate immune system. In summary, the rat 
i.d. model enables us to distinguish Bartonella factors involved on two different phases of 
the infection: early phase, prior seeding into the blood and the blood stage. On those two 
stages bacteria have different environment to interact with, and assumably different 
strategies to cope with the host immune system. 
 
In vivo relevance for BepE 
The rat i.d. infection model revealed BepE as a critical factor in the establishment of 
reservoir host bacteremia. The expression of BepEBtr could rescue the abacteremic 
phenotype of Btr ΔbepDE mutant and enabled the strain to reach the blood. Heterologous 
complementation of Btr ΔbepDE phenotype with BepEBhe suggests that this function of BepE 
is conserved between different species of Bartonellae. Even more, I could demonstrate that 
the C-terminal BID domains are having the specific function but putative phosphotyrosine-
containing N-term of BepE does not play an essential role in the establishment of long-term 
bacteremic infection of the natural host by Bartonella.  
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BepE a fine-tune mechanism of host cell manipulation by Bartonella 
Another phenotype of BepE but in vitro was observed during the infection of HUVECs with 
Bhe ΔbepE (and ΔbepDEF) mutant(s). HUVECs infected with Bhe stain that lacked BepEBhe 
revealed disturbed rear edge detachment during migration and followed with the 
fragmentation of cell body. This phenomenon was inhibited by pbepEBhe expression in Bhe 
ΔbepE (and ΔbepDEF) as well as, by T4SS independent expression of pbepEBhe in HUVECs by 
transfection prior the infection with Bhe ΔbepE (and ΔbepDEF). We found that the cell 
fragmentation of infected HUVECs is T4SS dependent and is a secondary effect of 
translocated Beps, potentially the Beps involved in the invasome formation. Further we 
conclude that the C-terminal BID domains of BepEBhe are sufficient to interfere with the 
fragmentation process. From this we could hypothesize that primary infected cells in i.d. 
infection model of rats may also undergo fragmentation or impaired migration when 
infected with Btr ΔbepDE and then Bartonella does not succeed to reach the blood system 
and colonize red blood cells. 
 
Potential “primay niche” cells for Bartonella in the reservoir host 
I introduced the i.d. in vivo infection of Rosa 26-loxP-egfp Balb/c mice and in vitro mouse 
Bone Marrow-derived Dendritic Cells (BMDCs) with B. birtlesii (Bbi) strain that is expressing 
Cre-BID fusion protein. The in vitro model showed for the first time Bartonella effector 
protein translocation in primary immune cells of the reservoir host. This finding builds a 
strong basis for the hypothesis that primary infected cells in vivo may be the DCs 
(Langerhance cells or dermal DCs) in the skin of infected animal. DCs are the sentinels of the 
immune system that constantly sample the environment for the “danger signal”. Thus, they 
represent one of the candidate cells in the derma to be targeted by Bartonella after 
inoculation of the bacteria from the feces of arthropod vector. Infected DCs could serve as 
Trojan horses to carry and disseminate Bartonella from derma to lymphatic–blood system. 
The time course of the i.d. infection of Rosa 26-loxP-egfp Balb/c mice with Bbi showed that 
bacteremia started at 4-5 days post infection (dpi). Thus, the time point to observe infected 
DCs migrated from derma to lymph nodes should be rather 3 dpi. 
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5. Outlook 
In this chapter I will highlight the open questions regarding the BepE function in vivo and 
interference with the cell fragmentation phenomenon and provide the suggestions of 
experimental setups that allow addressing the open points. In the end, I emphasize how 
the research carried out in the frame of my thesis may generate the impact by providing 
new insights on general microbiological and cell biological problems. 
The two phenotypes of BepE C-terminal BID domains were observed: (i) in vivo in the 
absence of BepE Btr ΔbepDE is not able to reach the blood, assumably bacteria are 
cleared by innate immune system at the site of infection or on the way to blood stream. 
(ii) in vitro HUVECs infected with the Bhe strains lacking BepE develop a problem to 
detach at the rear edge during migration and undergo subsequent fragmentation. 
Whether these two observations are the result of the same effect of Bartonella on 
infected cells and the primary infected cells in vivo also develop disturbed migration 
needs further elucidation. 
The mouse model, Rosa 26-loxP-egfp Balb/c i.d. infection with Bbi-Tn-cre, provides 
possibility to demonstrate the migration of primary infected cells to lymph nodes by 
detecting GFP-expressing cells in draining lymph nodes with FACS analysis or histological 
examination. Infection with Bbi-Tn-cre ΔbepE adds the possibility to detect the impaired 
migration of infected cells to the lymph nodes. The decreased numbers (or absence) of 
GFP-positive cells in lymph nodes could give a strong evidence that BepE is a factor in vivo 
that interferes with the impaired migration of infected cells. At the same time, it would 
help to understand whether GFP-expressing cells have migrated from the primary 
infection site, derma, or they are the resident cells of lymph node and infected with 
Bartonella already at the place of detection. 
On the other hand, the in vitro infectivity of BMDCs (from Rosa 26-loxP-egfp Balb/c) with 
Bbi-Tn-cre enables us to investigate the migration of potential target cells, DCs, in vitro. 
The homing factors for DC migration to lymph nodes, CCL19 and/or CCL21, may be used 
as a chemoattrachtant for Bbi-Tn-cre and Bbi-Tn-cre ΔbepE infected DCs to examine their 
migration properties in directional movement, thus mimicking the migration of infected 
DCs from derma to the nearest lymph node in respond to the chemoattractant gradient. 
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Bbi-Tn-cre and Bbi-Tn-cre ΔbepE infected BMDCs need to be investigated carefully for the 
expression of DC maturation markers and for upregulation of the adhesion molecules (ex. 
CCR7) for migration and effective stimulation of T cells. 
For the understanding of molecular mechanisms of cell fragmentation phenomenon of 
Bhe ΔbepE (and ΔbepDEF)-infected HUVECs, first the induction factor needs to be 
revealed. Our hypothesis that the phenotype is a secondary effect of the Beps involved in 
the formation of invasomes, can be investigated by infection of HUVECs with ΔbepB-G 
strain complemented with pbepB, pbepC and pbepG or different combinations even with 
pbepF. BepF involved in the invasome formation together with BepC [1], however we 
know that BepF alone does not induce the cell fragmentation. Once we know the 
responsible Bep(s) for the fragmentation we may introduce the BepE either by T4SS-
dependent or independent manner and rescue the phenotype. This would prove that 
Bartonella has evolved BepE as a fine-tune mechanism to compensate the drastic effects 
on host cell actin cytoskeleton when translocating Beps with invasome formation potence. 
Current evidence shows that BepE rescues cells from rear detachment problem 
potentially by refining the focal adhesion (FA) turnover. It is a subject of interest to have a 
closer look on different components of the FAs and their regulation. The use of Lenti-viral 
systems for visualization of focal adhesions could be a possibility to monitor FA turnover 
in Bhe ΔbepE (and ΔbepDEF) and Bhe ΔbepE-pbepE (and ΔbepDEF-pbepE)-infeted HUVECs. 
Of course with the interest to translate observed data on primary infected cells of the 
reservoir host of Bartonella. 
Another approach to understand the underlying molecular mechanism of fragmentation 
phenomenon is siRNA gene silencing of the signaling components that are involved in cell 
rear retraction. However, for that we first need to see a similar (if not the same) 
phenotype in the cell line, as HUVECs are not convenient for siRNA tarnsfection 
manipulations. 
The hypothesis of cell fragmentation next to invasome formation is strengthened by 
existing knowledge. Rac signaling is able to antagonize Rho activity directly at the GTPase 
level, and that the reciprocal balance between Rac and Rho activity determines cellular 
morphology and migratory behavior in NIH3T3 fibroblasts [2]. At the same time, it was 
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shown that invasome formation is mediated with Rac1/Scar1/WAVE/Arp2/3 pathway [1]. 
This Rac1 mediated Rho inhibition may be the event leading to impaired detachment of 
infected HUVECs. Lysophosphatidic acid (LPA)-mediated activation of Rho GTPase [2,3] 
may be one possibility to look at fragmentation recovery of Bhe ΔbepE (and ΔbepDEF)-
infected HUVECs.  
 
The impact of the study on general microbiology and cell biology 
Although the aim of my research was to increase the knowledge about BepE effector 
protein, certain aspects and established approaches may influence the other fields as well.  
The Rosa26 loxp-GFP Balb/c mouse line is primarily used for tissue specific expression of 
GFP after breading the line with the mice expressing Cre recombinase in different tissues, 
mainly in neurobiology field. The use of Rosa26 loxp-GFP Balb/c mouse line as a reporter 
for in vivo translocation of bacterial effectors was a first trial from our group on the 
example of Beps. Now, that we have strong evidence from in vivo experiments and we 
already showed in vitro infectivity of BMDCs by Bbi-Tn-cre, the reporter system can be 
broadly used for other pathogens and translocation systems. It provides a tool to chase in 
vivo targeted cells by a pathogen by visualizing effector translocation in infected cells 
even in a “bystander mechanism”, the translocation without bacterial entry into the cells.  
Most of the findings and the knowledge in cell migration accumulated after the use of 
bacterial factors targeting different components important for cell migration. These 
factors induce cytoskeleton rearangments by targeting regulator factors or directly 
mimicking them. The best example, amongst many others, is C3 toxin from Botulinum, 
the inhibitor of Rho GTPase [3,4]. In this regard the molecular mechanisms of BepE effect 
have a great importance, as it refines the rear detachment problem and seems to be 
actively involved in the regulation focal adhesion turn over in migrating cell. Thus, further 
research on BepE would provide new insights into cell biology by strengthening the 
knowledge or even revealing new mechanisms in the regulation of cell migration, which 
itself has a great importance in understanding of metastasis, angiogenesis, immune 
response and developmental biology. 
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